The Toro Company (TTC) 10-Q 1 Sep 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Jul. 29, 2022	Aug. 25, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 29, 2022
Document Transition Report	false
Entity File Number	1-8649
Entity Registrant Name	THE TORO COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	41-0580470
Entity Address, Address Line One	8111 Lyndale Avenue South
Entity Address, City or Town	Bloomington
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55420-1196
City Area Code	952
Local Phone Number	888-8801
Title of 12(b) Security	Common Stock, par value $1.00 per share
Trading Symbol	TTC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		104,202,639
Entity Central Index Key	0000737758
Amendment Flag	false
Current Fiscal Year End Date	--10-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Income Statement [Abstract]
Net sales	$ 1,160,550	$ 976,836	$ 3,342,678	$ 2,998,929
Cost of sales	760,644	645,719	2,236,927	1,949,823
Gross profit	399,906	331,117	1,105,751	1,049,106
Selling, general and administrative expense	236,858	209,178	680,500	604,986
Operating earnings	163,048	121,939	425,251	444,120
Interest expense	(9,182)	(7,016)	(24,219)	(21,662)
Other income, net	3,225	2,528	8,262	8,062
Earnings before income taxes	157,091	117,451	409,294	430,520
Provision for income taxes	31,941	21,131	83,509	80,748
Net earnings	$ 125,150	$ 96,320	$ 325,785	$ 349,772
Basic net earnings per share of common stock (in dollars per share)	$ 1.19	$ 0.90	$ 3.10	$ 3.25
Diluted net earnings per share of common stock (in dollars per share)	$ 1.19	$ 0.89	$ 3.08	$ 3.21
Weighted-average number of shares of common stock outstanding — Basic (in shares)	104,827	107,130	104,931	107,667
Weighted-average number of shares of common stock outstanding — Diluted (in shares)	105,448	108,363	105,754	108,818

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Statement of Comprehensive Income [Abstract]
Net earnings	$ 125,150	$ 96,320	$ 325,785	$ 349,772
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(5,792)	(5,314)	(21,190)	6,685
Derivative instruments, net of tax of $863; $2,641; $4,895; and $140, respectively	2,472	8,035	16,043	886
Other comprehensive income (loss), net of tax	(3,320)	2,721	(5,147)	7,571
Comprehensive income	$ 121,830	$ 99,041	$ 320,638	$ 357,343

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Statement of Comprehensive Income [Abstract]
Derivative instruments, tax	$ 863	$ 2,641	$ 4,895	$ 140

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
ASSETS
Cash and cash equivalents	$ 231,564	$ 405,612	$ 535,330
Receivables, net	350,657	310,279	301,234
Inventories, net	939,274	738,170	665,648
Prepaid expenses and other current assets	82,861	35,124	43,577
Total current assets	1,604,356	1,489,185	1,545,789
Property, plant, and equipment, net	531,816	487,731	456,992
Goodwill	583,803	421,680	421,958
Other intangible assets, net	595,141	420,041	426,497
Right-of-use assets	73,349	66,990	72,236
Investment in finance affiliate	31,389	20,671	19,272
Deferred income taxes	961	5,800	6,362
Other assets	19,134	24,042	18,943
Total assets	3,439,949	2,936,140	2,968,049
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt	65,000	0	104,217
Accounts payable	487,030	503,116	411,413
Accrued liabilities	443,557	419,620	427,407
Short-term lease liabilities	15,675	14,283	15,403
Total current liabilities	1,011,262	937,019	958,440
Long-term debt, less current portion	990,616	691,242	587,345
Long-term lease liabilities	60,921	55,752	60,002
Deferred income taxes	50,332	50,397	74,381
Other long-term liabilities	40,216	50,598	50,703
Stockholders’ equity:
Preferred stock, par value $1.00 per share, authorized 1,000,000 voting and 850,000 non-voting shares, none issued and outstanding	0	0	0
Common stock, par value $1.00 per share, authorized 175,000,000 shares; issued and outstanding 104,193,673 shares as of July 29, 2022, 106,440,513 shares as of July 30, 2021, and 105,205,734 shares as of October 31, 2021	104,194	105,206	106,441
Retained earnings	1,213,551	1,071,922	1,157,428
Accumulated other comprehensive loss	(31,143)	(25,996)	(26,691)
Total stockholders’ equity	1,286,602	1,151,132	1,237,178
Total liabilities and stockholders’ equity	$ 3,439,949	$ 2,936,140	$ 2,968,049

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Stock disclosures
Preferred stock, par value (in dollars per share)	$ 1	$ 1	$ 1
Preferred stock, issued (in shares)	0	0	0
Preferred stock, outstanding (in shares)	0	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1	$ 1
Common stock, authorized (in shares)	175,000,000	175,000,000	175,000,000
Common stock, issued (in shares)	104,193,673	105,205,734	106,440,513
Common stock, outstanding (in shares)	104,193,673	105,205,734	106,440,513
Voting preferred stock
Stock disclosures
Preferred stock, authorized (in shares)	1,000,000	1,000,000	1,000,000
Non-voting preferred stock
Stock disclosures
Preferred stock, authorized (in shares)	850,000	850,000	850,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021
Cash flows from operating activities:
Net earnings	$ 325,785	$ 349,772
Adjustments to reconcile net earnings to net cash provided by operating activities:
Non-cash income from finance affiliate	(5,814)	(4,694)
(Contributions to)/Distributions from finance affiliate, net	(4,905)	5,167
Depreciation of property, plant and equipment	54,269	55,301
Amortization of other intangible assets	24,760	17,493
Fair value step-up adjustment to acquired inventory	535	0
Compensation cost for stock-based compensation awards	17,105	16,176
Deferred income taxes	0	699
Other	3,358	(26)
Changes in operating assets and liabilities, net of the effect of acquisitions:
Receivables, net	(38,118)	(42,217)
Inventories, net	(173,000)	(20,080)
Prepaid expenses and other assets	(32,483)	(1,019)
Accounts payable, accrued liabilities, and other liabilities	(16,929)	100,563
Net cash provided by operating activities	154,563	477,135
Cash flows from investing activities:
Purchases of property, plant and equipment	(75,772)	(47,961)
Business combinations, net of cash acquired	(402,386)	(14,874)
Asset acquisitions, net of cash acquired	(7,225)	(27,176)
Proceeds from asset disposals	197	588
Proceeds from sale of a business	4,605	18,732
Net cash used in investing activities	(480,581)	(70,691)
Cash flows from financing activities:
Borrowings under debt arrangements	700,000	0
Repayments under debt arrangements	(335,000)	(100,000)
Proceeds from exercise of stock options	4,440	12,535
Payments of withholding taxes for stock awards	(2,308)	(1,875)
Purchases of TTC common stock	(110,004)	(177,152)
Dividends paid on TTC common stock	(94,401)	(84,677)
Net cash provided by (used in) financing activities	162,727	(351,169)
Effect of exchange rates on cash and cash equivalents	(10,757)	163
Net (decrease) increase in cash and cash equivalents	(174,048)	55,438
Cash and cash equivalents as of the beginning of the fiscal period	405,612	479,892
Cash and cash equivalents as of the end of the fiscal period	$ 231,564	$ 535,330

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2020	$ 1,114,828	$ 107,583	$ 1,041,507	$ (34,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(84,677)		(84,677)
Issuance of common stock	11,050	588	10,462
Stock-based compensation expense	16,176		16,176
Contribution of shares to a deferred compensation trust	1,485	23	1,462
Purchase of common stock	(179,027)	(1,753)	(177,274)
Other comprehensive income (loss)	7,571			7,571
Net earnings	349,772		349,772
Balance at end of period at Jul. 30, 2021	1,237,178	106,441	1,157,428	(26,691)
Balance at beginning of period at Apr. 30, 2021	1,229,417	107,043	1,151,786	(29,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(28,075)		(28,075)
Issuance of common stock	1,670	65	1,605
Stock-based compensation expense	5,831		5,831
Purchase of common stock	(70,706)	(667)	(70,039)
Other comprehensive income (loss)	2,721			2,721
Net earnings	96,320		96,320
Balance at end of period at Jul. 30, 2021	1,237,178	106,441	1,157,428	(26,691)
Balance at beginning of period at Oct. 31, 2021	1,151,132	105,206	1,071,922	(25,996)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(94,401)		(94,401)
Issuance of common stock	4,473	234	4,239
Stock-based compensation expense	17,105		17,105
Contribution of shares to a deferred compensation trust	(33)	(33)	0
Purchase of common stock	(112,312)	(1,213)	(111,099)
Other comprehensive income (loss)	(5,147)			(5,147)
Net earnings	325,785		325,785
Balance at end of period at Jul. 29, 2022	1,286,602	104,194	1,213,551	(31,143)
Balance at beginning of period at Apr. 29, 2022	1,223,516	104,568	1,146,771	(27,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(31,447)		(31,447)
Issuance of common stock	2,193	81	2,112
Stock-based compensation expense	5,972		5,972
Purchase of common stock	(35,462)	(455)	(35,007)
Other comprehensive income (loss)	(3,320)			(3,320)
Net earnings	125,150		125,150
Balance at end of period at Jul. 29, 2022	$ 1,286,602	$ 104,194	$ 1,213,551	$ (31,143)

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Statement of Stockholders' Equity [Abstract]
Cash dividends paid on common stock (in dollars per share)	$ 0.30	$ 0.2625	$ 0.90	$ 0.7875
Issuance of share-based payment awards (in shares)	80,153	64,260	233,491	587,723
Contribution to a deferred compensation trust (in shares)			33,162	22,700
Purchase of shares of common stock (in shares)	454,482	666,672	1,212,390	1,752,579

Basis of Presentation

Basis of Presentation	9 Months Ended
	Jul. 29, 2022
Accounting Policies [Abstract]
Basis of Presentation	1 Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States ("U.S.") generally accepted accounting principles ("GAAP") for complete financial statements. Unless the context indicates otherwise, the terms "company," "TTC," "we," "our," or "us" refer to The Toro Company and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated from the unaudited Condensed Consolidated Financial Statements. In the opinion of management, the unaudited Condensed Consolidated Financial Statements include all adjustments, consisting primarily of recurring accruals, considered necessary for the fair presentation of the company's consolidated financial position, results of operations, and cash flows for the periods presented. Due to seasonality within the industries in which the company's businesses operate, the effect of COVID-19 and the macroeconomic effects resulting therefrom on the Company's business and operating results, among other factors, operating results for the nine months ended July 29, 2022 cannot be annualized to determine the expected results for the fiscal year ending October 31, 2022. The company’s fiscal year ends on October 31 and quarterly results are reported based on three-month periods that generally end on the Friday closest to the calendar quarter end. For comparative purposes, however, the company’s second and third quarters always include exactly 13 weeks of results so that the quarter end date for these two quarters is not necessarily the Friday closest to the calendar month end. For further information regarding the company's basis of presentation, refer to the Consolidated Financial Statements and Notes to Consolidated Financial Statements included in the company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2021. The policies described in that report are used for preparing the company's quarterly reports on Form 10-Q. Impact of Russia's Invasion of Ukraine Beginning in the second quarter of fiscal 2022, in response to Russia's invasion of Ukraine, the company discontinued sales into the Russian and Belarus markets. Prior sales in those markets did not represent a significant share of our overall international business, and the company does not expect this decision to have a material impact on our financial results. Continuing Impact of COVID-19 COVID-19 is having lingering effects on public health and portions of the global economy. The company continues to see significant pressure on global supply chains rooted mainly in disruptions created by these effects. The continuing implications of COVID-19, including its variants, and the macroeconomic effects resulting therefrom, on the company remain uncertain and will depend on future developments, including any adverse impact due to additional variants of the virus; its impact on market demand for the company's products; its impact on the company's employees, customers, and suppliers; the range of government mandated restrictions and other measures; and the success of the COVID-19 vaccines and their effectiveness against the virus and related variants. This uncertainty could have a material impact on accounting estimates and assumptions utilized to prepare the Condensed Consolidated Financial Statements as of and for the nine months ended July 29, 2022 and in future reporting periods, which could result in a material adverse impact on the company's consolidated financial position, results of operations, and cash flows. Accounting Policies and Estimates In preparing the Condensed Consolidated Financial Statements in conformity with U.S. GAAP, management must make decisions that impact the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures, including disclosures of contingent assets and liabilities. Such decisions include the selection of the appropriate accounting principles to be applied and the assumptions on which to base accounting estimates. Estimates are used in determining, among other items, sales promotion and incentive accruals, incentive compensation accruals, income tax accruals, inventory valuation, warranty accruals, allowances for current expected credit losses, pension accruals, self-insurance accruals, legal accruals, right-of-use assets and lease liabilities, useful lives for tangible and finite-lived intangible assets, future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, and valuations of the assets acquired and liabilities assumed in a business combination or an asset acquisition, when applicable. These estimates and assumptions are based on management’s best estimates and judgments at the time they are made and are generally derived from management's understanding and analysis of the relevant and current circumstances, historical experience, and actuarial and other independent external third-party specialist valuations, when applicable. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors that management believes to be reasonable under the circumstances, including the economic environment. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with certainty, including those impacted by COVID-19 and Russia's invasion of Ukraine and the related sanctions and geopolitical tensions, actual amounts could differ significantly from those estimated at the time the Condensed Consolidated Financial Statements are prepared. New Accounting Pronouncements Adopted In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The amended guidance also clarifies and simplifies other aspects of the accounting for income taxes under accounting standards codification Topic 740, Income Taxes . The amended guidance was adopted in the first quarter of fiscal 2022 and did not have a material impact on the company's Condensed Consolidated Financial Statements. In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) , which clarified that before applying or upon discontinuing the equity method of accounting for an investment in equity securities, an entity should consider observable transactions that require it to apply or discontinue the equity method of accounting for the purposes of applying the fair value measurement alternative. The amended guidance was adopted in the first quarter of fiscal 2022 and did not have a material impact on the company's Condensed Consolidated Financial Statements. New Accounting Pronouncements Not Yet Adopted In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides temporary optional guidance to ease the potential burden of accounting for reference rate reform due to the cessation of the London Interbank Offered Rate, commonly referred to as "LIBOR." The temporary guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, relationships, and transactions affected by reference rate reform if certain criteria are met. The guidance was effective upon issuance on March 12, 2020 and the provisions of the temporary optional guidance provided by the ASU may be elected on a prospective basis from the beginning of an interim period that includes the issuance date of the ASU through December 31, 2022, when the reference rate reform activity is expected to be substantially complete. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope , to provide supplemental guidance and to further clarify the scope of the amended guidance. At this time, the company does not have receivables, hedging relationships, or operating lease agreements that reference LIBOR or another reference rate expected to be discontinued; and therefore, the company has not applied the optional practical expedients under this ASU to these classes of assets. On October 5, 2021, the company entered into an amended and restated credit agreement and at such time, the company concluded that the optional practical expedients provided by the ASU would not be elected as the required criteria were not met. The amended and restated credit agreement includes a transition clause in the event LIBOR is discontinued and the company's other fixed-rate financing agreements do not reference LIBOR or another reference rate expected to be discontinued. On April 27, 2022, the company amended its October 5, 2021 amended and restated revolving credit agreement to transition the reference rate from LIBOR to Secured Overnight Financing Rate ("SOFR"). As of July 29, 2022, SOFR is the reference rate in effect for all outstanding variable interest borrowings of the company. The company does not expect the transition of LIBOR to have a material impact on the company's Condensed Consolidated Financial Statements; however, a review of other contracts and agreements is underway and is expected to be completed prior to December 31, 2022. The company believes that all other recently issued accounting pronouncements from the FASB that the company has not noted above, will not have a material impact on its Condensed Consolidated Financial Statements or do not apply to its operations.

Business Combinations and Asset

Business Combinations and Asset Acquisitions	9 Months Ended
	Jul. 29, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combinations and Asset Acquisitions	2 Business Combinations and Asset Acquisitions Intimidator Group On January 13, 2022 ("closing date"), pursuant to an equity interest purchase agreement ("equity agreement"), the company acquired the privately-held Intimidator Group ("Intimidator"). Intimidator primarily designs, manufactures, markets, and sells a commercial-grade line of zero-turn mowers under the Spartan Mowers brand, which are intended to provide innovative turf management solutions to landscape contractors and other customers who require a commercial-grade solution. The acquisition of Intimidator broadened the company's Professional reportable segment and expanded its manufacturing footprint and dealer network. The Intimidator acquisition was structured as an equity purchase, pursuant to which the company acquired 100 percent of the equity interests of the legal entities that comprised Intimidator, with the legal entities continuing as surviving entities and wholly-owned subsidiaries of the company. As part of the acquisition, the company also acquired the real property used by Intimidator that was owned by an affiliate of Intimidator. As of the closing date, the aggregate purchase consideration was $398.9 million, subject to certain customary adjustments based on, among other things, the amount of actual cash, debt, and working capital in the business of Intimidator at the closing date. Such customary adjustments were finalized during the third quarter of fiscal 2022 and resulted in an aggregate purchase consideration of $399.8 million ("purchase price"). Additionally, the aggregate purchase consideration remains subject to contingent consideration through the end of calendar year 2022, in the event of certain qualifying tax changes. As a result, the company could be subject to additional cash purchase consideration for an amount not to exceed $15.0 million and remittance of such contingent consideration, if required, is due by March 15, 2023. As of July 29, 2022, no liability was recorded within the Condensed Consolidated Balance Sheets for the contingent consideration as the contingency is not probable or estimable. The company funded the purchase price with borrowings under its existing unsecured senior revolving credit facility and cash provided by operating activities. For additional information regarding the company's unsecured senior revolving credit facility utilized to fund the purchase price, refer to Note 6, Indebtedness . Purchase Price Allocation The company accounted for the acquisition in accordance with the accounting standards codification guidance for business combinations, whereby the aggregate purchase price was allocated to the acquired net tangible and intangible assets of Intimidator based on their fair values as of the closing date. As of July 29, 2022, the company has substantially completed its process for measuring the fair values of the assets acquired and liabilities assumed based on information available as of the closing date, with the exception of contingent consideration in the event of certain qualifying tax changes. The company expects to finalize its valuation and complete the allocation of the purchase price as soon as practicable but no later than one year from the closing date of the acquisition, as required. The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed. These fair values are based on internal company and independent external third-party valuations and are subject to change as certain asset and liability valuations are finalized: (Dollars in thousands) January 13, 2022 Cash and cash equivalents $ 975 Receivables 6,954 Inventories 34,608 Prepaid expenses and other current assets 513 Property, plant and equipment 27,447 Right-of-use assets 344 Goodwill 163,731 Other intangible assets: Indefinite-lived trade name 99,100 Finite-lived trade names 3,260 Finite-lived customer-related 80,500 Finite-lived backlog 1,340 Accounts payable (8,535) Accrued liabilities (9,152) Short-term lease liabilities (100) Long-term lease liabilities (244) Total fair value of net assets acquired 400,741 Less: cash and cash equivalents acquired (975) Total purchase price $ 399,766 The goodwill recognized is primarily attributable to the expected future cash flows, the value of the workforce, and expected synergies, including customer and dealer growth opportunities, expanding existing product lines, and cost reduction initiatives. Key areas of expected cost synergies include increased purchasing power for commodities, components, parts, and accessories and supply chain consolidation. The goodwill resulting from the acquisition of Intimidator was recognized within the company's Professional segment and is the primary driver for the increase in the company's Professional segment goodwill to $573.4 million as of July 29, 2022 as compared to $411.1 million as of October 31, 2021. The acquisition was considered an asset acquisition for income tax purposes and as a result, the goodwill arising from the transaction is deductible. As permitted under the accounting standards codification guidance for business combinations, the company recorded increases to the carrying value of goodwill of $2.9 million and $8.1 million for the three and nine months ended July 29, 2022, respectively, as a result of revising the Intimidator purchase price for certain customary adjustments. Such purchase accounting adjustment did not impact the company's Consolidated Statements of Earnings for the three and nine month periods ended July 29, 2022. Other Intangible Assets Acquired The allocation of the purchase price to the net assets acquired resulted in the recognition of $184.2 million of value for other intangible assets as of the closing date. The fair values of the acquired trade names, customer-related, and backlog intangible assets were determined using the income approach whereby an intangible asset's fair value is equal to the present value of future economic benefits to be derived from ownership of the asset. The useful lives of the other intangible assets were determined based on the period of expected cash flows used to measure the fair value of the intangible assets adjusted as appropriate for entity-specific factors including legal, regulatory, contractual, competitive, economic, and/or other factors that may limit the useful life of the respective intangible asset. As of the closing date, the acquired finite-lived intangible assets had a weighted average useful life of 9.5 years. The fair values of the trade names were determined using the relief from royalty method, which is based on the hypothetical royalty stream that would be received if the company were to license the respective trade name and were based on expected future revenues from the respective trade name. The weighted-average useful life of the finite-lived trade name intangible assets was determined to be 9.8 years as of the closing date. The fair values of the customer-related and backlog intangible assets were determined using the excess earnings method and were based on the expected operating cash flows attributable to the respective intangible asset, which were determined by deducting expected economic costs, including operating expenses and contributory asset charges, from the revenue expected to be generated from the respective intangible asset. As of the closing date of the acquisition, the weighted-average useful life of the customer-related and backlog intangible assets were determined to be 9.6 years and 9 months, respectively. Results of Operations Intimidator's results of operations are included within the company's Professional reportable segment in the company's Condensed Consolidated Financial Statements from the closing date. For the three and nine months ended July 29, 2022, the company recognized $54.4 million and $114.9 million of net sales from Intimidator's operations, respectively. Intimidator's operations had an immaterial impact on Professional segment earnings for the three and nine month periods ended July 29, 2022. Unaudited pro forma financial information is not disclosed as the Intimidator acquisition was not considered material to the company's consolidated results of operations. Asset Acquisitions Effective June 10, 2022, during the third quarter of fiscal 2022, the company completed the acquisition of certain assets of Voigt Smith Innovation LLC (“VSI”), a manufacturer of liquid deicing equipment, brine makers and applicators, related smart-connected technologies, and hydroseeding products. Effective June 20, 2022, during the third quarter of fiscal 2022, the company completed the acquisition of certain assets of Tornado Global Hydrovacs Ltd. (“Tornado”), a designer and manufacturer of hydrovac trucks. Effective June 21, 2022, during the third quarter of fiscal 2022, the company completed the acquisition of certain assets of River City Manufacturing, Inc. (“RCM”), a manufacturer of custom rock saws. Each of these acquisitions did not meet the definition of a business combination as substantially all of the fair value of the gross assets acquired in each acquisition was concentrated in the respective finite-lived developed technology intangible assets. As a result, the company accounted for each of these transactions as an asset acquisition. In an asset acquisition, goodwill is not recognized, but rather, any excess purchase consideration over the fair value of the net assets acquired is allocated on a relative fair value basis to the identifiable net assets as of the acquisition date and any direct acquisition-related transaction costs are capitalized as part of the purchase consideration. These asset acquisitions were immaterial in relation to the company's Consolidated Financial Condition and Results of Operations and as a result, additional purchase accounting disclosures have been omitted.

Segment Data

Segment Data	9 Months Ended
	Jul. 29, 2022
Segment Reporting [Abstract]
Segment Data	3 Segment Data The company's businesses are organized, managed, and internally grouped into segments based on similarities in products and services. Segment selection is based on the manner in which the company's chief operating decision maker organizes segments for making operating and investment decisions and assessing performance. The company has identified twelve operating segments and has aggregated certain of those operating segments into two reportable segments: Professional and Residential. The aggregation of the company's segments is based on the segments having the following similarities: economic characteristics, types of products and services, types of production processes, type or class of customers, and method of distribution. The company's remaining activities are presented as "Other" due to their insignificance. The company's Other activities consist of the company's wholly-owned domestic distribution company, the company's corporate activities, and the elimination of intersegment revenues and expenses. The following tables present summarized financial information concerning the company’s reportable business segments and Other activities (in thousands): Three Months Ended July 29, 2022 Professional Residential Other Total Net sales $ 886,232 $ 269,962 $ 4,356 $ 1,160,550 Intersegment gross sales (eliminations) 10,436 15 (10,451) — Earnings (loss) before income taxes $ 166,191 $ 26,348 $ (35,448) $ 157,091 Nine Months Ended July 29, 2022 Professional Residential Other Total Net sales $ 2,484,927 $ 845,039 $ 12,712 $ 3,342,678 Intersegment gross sales (eliminations) 23,201 50 (23,251) — Earnings (loss) before income taxes 424,833 95,203 (110,742) 409,294 Total assets $ 2,625,481 $ 407,218 $ 407,250 $ 3,439,949 Three Months Ended July 30, 2021 Professional Residential Other Total Net sales $ 718,477 $ 252,117 $ 6,242 $ 976,836 Intersegment gross sales (eliminations) 8,241 13 (8,254) — Earnings (loss) before income taxes $ 122,331 $ 31,548 $ (36,428) $ 117,451 Nine Months Ended July 30, 2021 Professional Residential Other Total Net sales $ 2,197,058 $ 784,852 $ 17,019 $ 2,998,929 Intersegment gross sales (eliminations) 24,034 39 (24,073) — Earnings (loss) before income taxes 406,279 109,642 (85,401) 430,520 Total assets $ 1,949,681 $ 327,064 $ 691,304 $ 2,968,049 The following table presents the details of operating loss before income taxes for the company's Other activities: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Corporate expenses $ (30,816) $ (33,797) $ (94,359) $ (78,814) Interest expense (9,182) (7,016) (24,219) (21,662) Earnings from wholly-owned domestic distribution companies and other income, net 4,550 4,385 7,836 15,075 Total operating loss $ (35,448) $ (36,428) $ (110,742) $ (85,401)

Revenue

Revenue	9 Months Ended
	Jul. 29, 2022
Revenue from Contract with Customer [Abstract]
Revenue	4 Revenue The following tables disaggregate the company's reportable segment net sales by major product type and geographic market (in thousands): Three Months Ended July 29, 2022 Professional Residential Other Total Revenue by product type: Equipment $ 780,738 $ 265,469 $ 1,102 $ 1,047,309 Irrigation 105,494 4,493 3,254 113,241 Total net sales $ 886,232 $ 269,962 $ 4,356 $ 1,160,550 Revenue by geographic market: United States $ 710,386 $ 229,666 $ 4,356 $ 944,408 International countries 175,846 40,296 — 216,142 Total net sales $ 886,232 $ 269,962 $ 4,356 $ 1,160,550 Nine Months Ended July 29, 2022 Professional Residential Other Total Revenue by product type: Equipment $ 2,149,549 $ 823,536 $ 6,207 $ 2,979,292 Irrigation 335,378 21,503 6,505 363,386 Total net sales $ 2,484,927 $ 845,039 $ 12,712 $ 3,342,678 Revenue by geographic market: United States $ 1,969,933 $ 703,234 $ 12,712 $ 2,685,879 International countries 514,994 141,805 — 656,799 Total net sales $ 2,484,927 $ 845,039 $ 12,712 $ 3,342,678 Three Months Ended July 30, 2021 Professional Residential Other Total Revenue by product type: Equipment $ 609,022 $ 247,152 $ 3,164 $ 859,338 Irrigation 109,455 4,965 3,078 117,498 Total net sales $ 718,477 $ 252,117 $ 6,242 $ 976,836 Revenue by geographic market: United States $ 559,907 $ 219,022 $ 6,242 $ 785,171 International countries 158,570 33,095 — 191,665 Total net sales $ 718,477 $ 252,117 $ 6,242 $ 976,836 Nine Months Ended July 30, 2021 Professional Residential Other Total Revenue by product type: Equipment $ 1,891,138 $ 761,724 $ 11,436 $ 2,664,298 Irrigation 305,920 23,128 5,583 334,631 Total net sales $ 2,197,058 $ 784,852 $ 17,019 $ 2,998,929 Revenue by geographic market: United States $ 1,681,972 $ 661,017 $ 17,019 $ 2,360,008 International countries 515,086 123,835 — 638,921 Total net sales $ 2,197,058 $ 784,852 $ 17,019 $ 2,998,929 Contract Liabilities Contract liabilities relate to deferred revenue recognized for cash consideration received at contract inception in advance of the company's performance under the respective contract and generally relate to the sale of separately priced extended warranty contracts, service contracts, and non-refundable customer deposits. The company recognizes revenue over the term of the contract in proportion to the costs expected to be incurred in satisfying the performance obligations under the separately priced extended warranty and service contracts. For non-refundable customer deposits, the company recognizes revenue as of the point in time in which the performance obligation has been satisfied under the contract with the customer, which typically occurs upon change in control at the time a product is shipped. As of July 29, 2022 and October 31, 2021, $27.3 million and $24.1 million, respectively, of deferred revenue associated with outstanding separately priced extended warranty contracts, service contracts, and non-refundable customer deposits was reported within accrued liabilities and other long-term liabilities in the Condensed Consolidated Balance Sheets. For the three and nine months ended July 29, 2022, the company recognized $3.3 million and $8.8 million, respectively, of the October 31, 2021 deferred revenue balance within net sales in the Condensed Consolidated Statements of Earnings. The company expects to recognize approximately $2.3 million of the October 31, 2021 deferred revenue amount within net sales throughout the remainder of fiscal 2022, $7.7 million in fiscal 2023, and $5.3 million thereafter.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets, Net	9 Months Ended
	Jul. 29, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets, Net	5 Goodwill and Other Intangible Assets, Net The company's acquisition of Intimidator on January 13, 2022 resulted in the recognition of $163.7 million and $184.2 million of goodwill and other intangible assets, respectively. For additional information on the company's acquisition of Intimidator, refer to Note 2, Business Combinations and Asset Acquisitions . Goodwill The changes in the carrying amount of goodwill by reportable segment for the first nine months of fiscal 2022 were as follows: (Dollars in thousands) Professional Residential Other Total Balance as of October 31, 2021 $ 411,079 $ 10,601 $ — $ 421,680 Goodwill acquired 163,731 — — 163,731 Translation adjustments (1,395) (213) — (1,608) Balance as of July 29, 2022 $ 573,415 $ 10,388 $ — $ 583,803 Other Intangible Assets, Net The components of other intangible assets, net as of July 29, 2022, July 30, 2021, and October 31, 2021 were as follows (in thousands): July 29, 2022 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,252 $ (15,178) $ 3,074 Non-compete agreements 5.5 6,887 (6,861) 26 Customer-related 16.0 321,113 (78,017) 243,096 Developed technology 7.1 102,013 (50,412) 51,601 Trade names 13.7 10,689 (3,267) 7,422 Backlog and other 0.6 5,730 (5,280) 450 Total finite-lived 13.4 464,684 (159,015) 305,669 Indefinite-lived - trade names 289,472 — 289,472 Total other intangible assets, net $ 754,156 $ (159,015) $ 595,141 July 30, 2021 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,275 $ (14,482) $ 3,793 Non-compete agreements 5.5 6,908 (6,861) 47 Customer-related 18.2 239,762 (59,017) 180,745 Developed technology 7.0 87,512 (40,943) 46,569 Trade names 15.3 7,544 (2,882) 4,662 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 14.6 364,391 (128,575) 235,816 Indefinite-lived - trade names 190,681 — 190,681 Total other intangible assets, net $ 555,072 $ (128,575) $ 426,497 October 31, 2021 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,283 $ (14,670) $ 3,613 Non-compete agreements 5.5 6,914 (6,872) 42 Customer-related 18.2 239,679 (62,617) 177,062 Developed technology 7.0 87,473 (43,348) 44,125 Trade names 15.4 7,524 (2,969) 4,555 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 14.6 364,263 (134,866) 229,397 Indefinite-lived - trade names 190,644 — 190,644 Total other intangible assets, net $ 554,907 $ (134,866) $ 420,041 Amortization expense for finite-lived intangible assets for the three and nine months ended July 29, 2022 was $9.1 million and $24.8 million, respectively. Amortization expense for finite-lived intangible assets for the three and nine months ended July 30, 2021 was $6.4 million and $17.5 million, respectively. Estimated amortization expense for the remainder of fiscal 2022 and succeeding fiscal years is as follows: fiscal 2022 (remainder), $9.1 million; fiscal 2023, $34.9 million; fiscal 2024, $33.0 million; fiscal 2025, $30.1 million; fiscal 2026, $29.0 million; fiscal 2027, $24.0 million; and after fiscal 2027, $145.6 million.

Indebtedness

Indebtedness	9 Months Ended
	Jul. 29, 2022
Debt Disclosure [Abstract]
Indebtedness	6 Indebtedness The following is a summary of the company's indebtedness: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 $600 million revolving credit facility, due October 2026 $ 65,000 $ — $ — $200 million term loan, due April 2022 — 100,000 — $300 million term loan, due April 2024 — 170,000 — $270 million term loan, due October 2026 270,000 — 270,000 $200 million term loan, due April 2027 200,000 — — 3.81% series A senior notes, due June 2029 100,000 100,000 100,000 3.91% series B senior notes, due June 2031 100,000 100,000 100,000 3.97% senior notes, due June 2032 100,000 — — 7.8% debentures, due June 2027 100,000 100,000 100,000 6.625% senior notes, due May 2037 124,086 124,024 124,040 Less: unamortized discounts, debt issuance costs, and deferred charges 3,470 2,462 2,798 Total long-term debt 1,055,616 691,562 691,242 Less: current portion of long-term debt 65,000 104,217 — Long-term debt, less current portion $ 990,616 $ 587,345 $ 691,242 Principal payments required on the company's outstanding indebtedness, based on the maturity dates defined within the company's debt arrangements, for the remainder of fiscal 2022 and succeeding fiscal years are as follows: fiscal 2022 (remainder), $0.0 million; fiscal 2023, $0.0 million; fiscal 2024, $0.0 million; fiscal 2025, $37.0 million; fiscal 2026, $328.0 million; fiscal 2027, $270.0 million; and after fiscal 2027, $425.0 million. Typically, the company's revolving credit facility is classified as long-term debt within the Condensed Consolidated Balance Sheets as the company has the ability to extend the outstanding borrowings under the revolving credit facility for the full-term of the facility. However, if the company intends to prepay a portion of the outstanding balance under the revolving credit facility within the next twelve months, the company reclassifies the portion of outstanding borrowings under the revolving credit facility that the company intends to repay within the next twelve months to current portion of long-term debt within the Condensed Consolidated Balance Sheets. As of July 29, 2022, the company reclassified $65.0 million of outstanding borrowings under the revolving credit facility to current portion of long-term debt within the Condensed Consolidated Balance Sheets as the company currently intends to repay this amount within the next twelve months. 3.97% Senior Notes On June 30, 2022, the company issued $100.0 million of 3.97% Senior Notes due June 30, 2032 ("3.97% Senior Notes") pursuant to a private placement note purchase agreement ("2022 Note Purchase Agreement") with certain purchasers ("holders"). The proceeds were used pay down certain of its outstanding borrowings incurred in connection with the company's acquisition of Intimidator on January 13, 2022 and borrowed under its revolving credit facility provided under an amended and restated revolving credit agreement dated as of October 5, 2021. In connection with the 2022 Note Purchase Agreement, the company incurred immaterial debt issuance costs, which were capitalized as contra-debt on our Condensed Consolidated Balance Sheets and will be amortized over the life of the 3.97% Senior Notes. Interest on the 3.97% Senior Notes is payable semiannually on the 30th day of June and December in each year. The 3.97% Senior Notes are unsecured senior obligations of the company and mature on June 30, 2032. The company has the right to prepay all or a portion of the 3.97% Senior Notes upon notice to the holders for 100% of the prepaid principal amount plus a make-whole premium, as set forth in the 2022 Note Purchase Agreement, plus accrued and unpaid interest, if any, to the date of prepayment. In addition, at any time during the 90 day period ending on the maturity date of the 3.97% Senior Notes, the company will have the right to prepay all of the 3.97% Senior Notes without any make-whole premium. Upon the occurrence of certain change of control events, holders of the 3.97% Senior Notes will have the right to require that the company purchase such holder’s 3.97% Senior Notes in cash at a purchase price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, to the date of repurchase. The 2022 Note Purchase Agreement contains customary representations and warranties of the company, as well as certain customary covenants, including, without limitation, financial covenants generally consistent with those applicable under the company's revolving credit facility. The company was in compliance with all covenants as of July 29, 2022. $200.0 Million Term Loan Credit Agreement On April 27, 2022, the company entered into a term loan credit agreement ("$200.0 million term loan") with certain financial institutions for the purpose of paying down certain of its outstanding borrowings incurred in connection with the company's acquisition of Intimidator on January 13, 2022 and borrowed under its revolving credit facility provided under an amended and restated revolving credit agreement dated as of October 5, 2021. The entire $200.0 million available under the agreement was funded on April 27, 2022, and matures on April 27, 2027. In connection with the company's entry into the $200.0 million term loan, the company incurred immaterial debt issuance costs, which are being deferred and amortized over the life of the $200.0 million term loan and are netted against the outstanding borrowings under the $200.0 million term loan within the long-term debt, less current portion line item on the company's Condensed Consolidated Balance Sheets. Outstanding borrowings under the $200.0 million term loan bear interest on the outstanding principal amount thereof for each interest period at a variable rate generally based on Term SOFR or an alternative variable rate based on the highest of the Bank of America prime rate, the federal funds rate or a rate generally based on Term SOFR, depending on the leverage ratio (as measured quarterly and defined as the ratio of (i) total indebtedness to (ii) consolidated EBIT (earnings before interest and taxes) plus depreciation and amortization expense) and our debt rating. Interest is payable quarterly in arrears. Beginning with the last business day of June 2025, the company is required to make quarterly amortization payments on the $200.0 million term loan equal to 2.5% of the original aggregate principal amount reduced by any applicable prepayments. The $200.0 million term loan may be prepaid and terminated at the company's election at any time without penalty or premium. Amounts repaid or prepaid may not be reborrowed. The $200.0 million term loan contains customary covenants, including, without limitation, financial covenants generally consistent with those applicable under the company's revolving credit facility. The company was in compliance with all covenants as of July 29, 2022. Revolving Credit Facility On April 27, 2022, the company amended its October 5, 2021 amended and restated revolving credit agreement to transition the reference rate from LIBOR to term SOFR. As of July 29, 2022, SOFR is the reference rate in effect for all outstanding variable interest borrowings of the company.

Inventories, Net

Inventories, Net	9 Months Ended
	Jul. 29, 2022
Inventory Disclosure [Abstract]
Inventories, Net	7 Inventories, Net Inventories are valued at the lower of cost or net realizable value, with cost determined by the first-in, first-out ("FIFO") and average cost methods for a majority of the company's inventories. All remaining inventories are valued at the lower of cost or market, with cost determined under the last-in, first-out ("LIFO") method. As needed, the company records an inventory valuation adjustment for excess, slow-moving, and obsolete inventory that is equal to the excess of the cost of the inventory over the estimated net realizable value or market value for the inventory depending on the inventory costing method. Such inventory valuation adjustment is based on a review and comparison of current inventory levels to planned production, as well as planned and historical sales of the inventory. The inventory valuation adjustment to net realizable value or market value establishes a new cost basis of the inventory that cannot be subsequently reversed. On January 13, 2022, with the acquisition of Intimidator, the company acquired $34.6 million of inventory. For additional information on the company's acquisition of Intimidator, refer to Note 2, Business Combinations and Asset Acquisitions . Inventories, net were as follows: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Raw materials and work in process $ 402,719 $ 280,774 $ 335,325 Finished goods and service parts 672,042 466,961 538,332 Total FIFO and average cost value 1,074,761 747,735 873,657 Less: adjustment to LIFO value 135,487 82,087 135,487 Total inventories, net $ 939,274 $ 665,648 $ 738,170

Property, Plant and Equipment,

Property, Plant and Equipment, Net	9 Months Ended
	Jul. 29, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	8 Property, Plant and Equipment, Net Property, plant and equipment assets are carried at cost less accumulated depreciation. The company generally accounts for depreciation of property, plant, and equipment utilizing the straight-line method over the estimated useful lives of the assets. Buildings and leasehold improvements are generally depreciated over 10 to 40 years, machinery and equipment are generally depreciated over three three two On January 13, 2022, with the acquisition of Intimidator, the company acquired $27.4 million of property, plant, and equipment. For additional information on the company's acquisition of Intimidator, refer to Note 2, Business Combinations and Asset Acquisitions . Property, plant and equipment, net was as follows: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Land and land improvements $ 57,169 $ 56,004 $ 57,690 Buildings and leasehold improvements 326,111 299,484 308,217 Machinery and equipment 535,303 508,383 522,012 Tooling 221,290 233,171 220,966 Computer hardware and software 96,834 102,293 97,485 Construction in process 141,503 82,211 85,722 Property, plant, and equipment, gross 1,378,210 1,281,546 1,292,092 Less: accumulated depreciation 846,394 824,554 804,361 Property, plant, and equipment, net $ 531,816 $ 456,992 $ 487,731

Product Warranty Guarantees

Product Warranty Guarantees	9 Months Ended
	Jul. 29, 2022
Product Warranties Disclosures [Abstract]
Product Warranty Guarantees	9 Product Warranty Guarantees The company’s products are warranted to provide assurance that the product will function as expected and to ensure customer confidence in design, workmanship, and overall quality. Standard warranty coverage is generally provided for specified periods of time and on select products’ hours of usage, and generally covers parts, labor, and other expenses for non-maintenance repairs. In addition to the standard warranties offered by the company on its products, the company also sells separately priced extended warranty coverage on select products for a prescribed period after the original warranty period expires. For additional information on the contract liabilities associated with the company's separately priced extended warranties, refer to Note 4, Revenue . At the time of sale, the company recognizes expense and records an accrual by product line for estimated costs in connection with forecasted future warranty claims. The company's estimate of the cost of future warranty claims is based primarily on the estimated number of products under warranty, historical average costs incurred to service warranty claims, the trend in the historical ratio of claims to sales, and the historical length of time between the sale and resulting warranty claim. The company periodically assesses the adequacy of its warranty accruals based on changes in these factors and records any necessary adjustments if the cost of actual claims experience indicates that adjustments to the company's warranty accrual are necessary. Additionally, from time to time, the company may also establish warranty accruals for its estimate of the costs necessary to settle major rework campaigns on a product-specific basis during the period in which the circumstances giving rise to the major rework campaign become known and when the costs to satisfactorily address the situation are both probable and estimable. The warranty accrual for the cost of a major rework campaign is primarily based on an estimate of the cost to repair each affected unit and the number of affected units expected to be repaired. The changes in accrued warranties were as follows: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Beginning balance $ 126,830 $ 119,389 $ 116,783 $ 107,121 Provisions 21,824 17,686 62,917 56,204 Acquisitions 2,466 — 5,663 — Claims (20,829) (20,300) (54,601) (51,104) Changes in estimates 727 377 256 4,931 Ending balance $ 131,018 $ 117,152 $ 131,018 $ 117,152

Investment in Finance Affiliate

Investment in Finance Affiliate	9 Months Ended
	Jul. 29, 2022
Equity Method Investments and Joint Ventures [Abstract]
Investment in Finance Affiliate	10 Investment in Finance Affiliate The company and TCF Inventory Finance, Inc. ("TCFIF"), a subsidiary of The Huntington National Bank, are parties to the Red Iron joint venture ("Red Iron"), the primary purpose of which is to provide inventory financing to certain distributors and dealers of certain of the company’s products in the U.S. These financing transactions are structured as an advance in the form of a payment by Red Iron to the company on behalf of a distributor or dealer with respect to invoices financed by Red Iron. These payments extinguish the obligation of the dealer or distributor to make payment to the company under the terms of the applicable invoice. The company has also entered into a limited inventory repurchase agreement with Red Iron, under which the company has agreed to repurchase certain repossessed products, up to a maximum aggregate amount of $7.5 million in a calendar year. The company's financial exposure under this limited inventory repurchase agreement is limited to the difference between the amount paid for repurchases of repossessed product and the amount received upon the subsequent resale of the repossessed product. The company has repurchased immaterial amounts of inventory under this limited inventory repurchase agreement for the nine months ended July 29, 2022 and July 30, 2021. Under separate agreements between Red Iron and the dealers and distributors, Red Iron provides loans to the dealers and distributors for the advances paid by Red Iron to the company. The net amount of receivables financed for dealers and distributors under this arrangement for the nine months ended July 29, 2022 and July 30, 2021 were $1,886.1 million and $1,733.0 million, respectively. As of July 29, 2022, Red Iron’s total assets were $641.6 million and total liabilities were $571.9 million. The total amount of receivables due from Red Iron to the company as of July 29, 2022, July 30, 2021, and October 31, 2021 were $14.4 million, $13.8 million and $31.0 million, respectively. The company owns 45 percent of Red Iron and TCFIF owns 55 percent of Red Iron. The company accounts for its investment in Red Iron under the equity method of accounting. At inception, the company and TCFIF each contributed a specified amount of the estimated cash required to enable Red Iron to purchase the company’s inventory financing receivables and to provide financial support for Red Iron’s inventory financing programs. Red Iron borrows the remaining requisite estimated cash utilizing a $625.0 million secured revolving credit facility established under a credit agreement between Red Iron and TCFIF. The company’s total investment in Red Iron as of July 29, 2022, July 30, 2021, and October 31, 2021 was $31.4 million, $19.3 million, and $20.7 million, respectively. The company has not guaranteed the outstanding indebtedness of Red Iron.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Jul. 29, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	11 Stock-Based Compensation Compensation costs related to stock-based compensation awards were as follows: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Stock option awards $ 2,664 $ 2,614 $ 7,207 $ 7,271 Performance share awards 1,697 2,184 5,235 5,205 Restricted stock unit awards 1,611 1,033 4,034 3,029 Unrestricted common stock awards — — 629 671 Total compensation cost for stock-based compensation awards $ 5,972 $ 5,831 $ 17,105 $ 16,176 On March 15, 2022, the company’s shareholders approved The Toro Company 2022 Equity and Incentive Plan (the “2022 plan”), which became effective immediately and replaced The Toro Company Amended and Restated 2010 Equity and Incentive Plan, as amended (the “2010 plan”). The 2022 plan is administered by the Compensation & Human Resources Committee of the Board and permits the grant of nonqualified and incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, annual performance awards, non-employee director awards and other cash-based and stock-based awards to eligible individuals. Subject to adjustment as provided in the 2022 plan, the maximum aggregate number of shares of the company’s common stock authorized for issuance under the 2022 plan is equal to the sum of: (a) 1,250,000 shares, plus (b) the number of shares remaining available for grant under the 2010 plan but not subject to outstanding awards thereunder as of March 15, 2022, and plus (c) the number of shares subject to awards outstanding under the 2010 plan as of March 15, 2022 but only to the extent that such outstanding awards are forfeited, expire or otherwise terminate without the issuance of such shares. Stock Option Awards Stock options are granted with an exercise price equal to the closing price of the company’s common stock on the date of grant, as reported by the New York Stock Exchange. Options are generally granted to executive officers, other employees, and non-employee members of the company’s Board of Directors ("Board") on an annual basis in the first quarter of the company’s fiscal year but may also be granted throughout the fiscal year in connection with hiring, mid-year promotions, leadership transition, or retention, as needed and applicable. Options generally vest one-third each year over a three-year period and have a ten-year term but in certain circumstances, the vesting requirement may be modified such that options granted to certain employees vest in full on the three-year anniversary of the date of grant and have a ten-year term. Compensation cost equal to the grant date fair value determined under the Black-Scholes valuation method is generally recognized for these awards over the vesting period. Compensation cost recognized for other employees not considered executive officers and non-employee Board members is net of estimated forfeitures, which are determined at the time of grant based on historical forfeiture experience. Stock options granted to executive officers and other employees are subject to accelerated expensing if the option holder meets the retirement definition set forth in the 2022 plan or 2010 plan, as applicable. In that case, the fair value of the options is expensed in the fiscal year of grant because generally, if the option holder is employed as of the end of the fiscal year in which the options are granted, such options will not be forfeited but continue to vest according to their schedule following retirement. Similarly, if a non-employee Board member has served on the company's Board for ten The fair value of each stock option is estimated on the date of grant using various inputs and assumptions under the Black-Scholes valuation method. The expected life is a significant assumption as it determines the period for which the risk-free interest rate, stock price volatility, and dividend yield must be applied. The expected life is the average length of time in which executive officers, other employees, and non-employee Board members are expected to exercise their stock options, which is primarily based on historical exercise experience. The company groups executive officers and non-employee Board members for valuation purposes based on similar historical exercise behavior. Expected stock price volatility is based on the daily movement of the company’s common stock over the most recent historical period equivalent to the expected life of the option. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate over the expected life at the time of grant. The expected dividend yield is estimated over the expected life based on the company’s historical cash dividends paid, expected future cash dividends and dividend yield, and expected changes in the company’s stock price. The table below illustrates the weighted-average valuation assumptions used under the Black-Scholes valuation method for options granted in the first nine months of the following fiscal periods: Fiscal 2022 Fiscal 2021 Expected life of option in years 6.19 6.21 Expected stock price volatility 23.74% 23.26% Risk-free interest rate 1.31% 0.55% Expected dividend yield 0.94% 0.86% Per share weighted-average fair value at date of grant $22.55 $19.39 Performance Share Awards The company grants performance share awards to executive officers and other employees under which they are entitled to receive shares of the company’s common stock contingent on the achievement of performance goals of the company, which are generally measured over a three-year period. The number of shares of common stock a participant receives can be increased (up to 200 percent of target levels) or reduced (down to zero) based on the level of achievement of performance goals and will vest at the end of a three-year period. Performance share awards are generally granted on an annual basis in the first quarter of the company’s fiscal year. Compensation cost is recognized for these awards on a straight-line basis over the vesting period based on the per share fair value, which is equal to the closing price of the company's common stock on the date of grant, and the probability of achieving each performance goal. The per share weighted-average fair value of performance share awards granted during the first quarter of fiscal 2022 and 2021 was $98.41 and $90.59, respectively. No performance share awards were granted during the second or third quarters of fiscal 2022 and 2021. Restricted Stock Unit Awards Restricted stock unit awards are generally granted to certain employees who are not executive officers. Occasionally, restricted stock unit awards may be granted, including to executive officers, in connection with hiring, mid-year promotions, leadership transition, or retention. Restricted stock unit awards generally vest one-third each year over a three-year period, or vest in full on the three-year anniversary of the date of grant. Compensation cost equal to the grant date fair value, net of estimated forfeitures, is recognized for these awards over the vesting period. The grant date fair value is equal to the closing price of the company's common stock on the date of grant multiplied by the number of shares subject to the restricted stock unit awards and estimated forfeitures are determined on the grant date based on historical forfeiture experience. The per share weighted-average fair value of restricted stock unit awards granted during the first nine months of fiscal 2022 and 2021 was $89.19 and $97.84, respectively. Unrestricted Common Stock Awards During the first nine months of fiscal 2022 and 2021, 6,453 and 8,070 shares, respectively, of fully vested unrestricted common stock awards were granted to certain Board members as a component of their compensation for their service on the Board and were recorded within selling, general and administrative expense in the Condensed Consolidated Statements of Earnings. Additionally, the Company's Board members may elect to convert a portion or all of their calendar year annual retainers otherwise payable in cash into shares of the company's common stock. No shares of fully vested unrestricted common stock awards were granted during the second or third quarters of fiscal 2022 and 2021.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Jul. 29, 2022
Stockholders' Equity Note [Abstract]
Stockholders' Equity	12 Stockholders' Equity Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss ("AOCL"), net of tax, within the Condensed Consolidated Statements of Stockholders' Equity were as follows: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Foreign currency translation adjustments $ 40,725 $ 17,823 $ 19,535 Pension benefits 3,899 5,106 3,899 Cash flow derivative instruments (13,481) 3,762 2,562 Total accumulated other comprehensive loss $ 31,143 $ 26,691 $ 25,996 The components and activity of AOCL, net of tax, for the three and nine month periods ended July 29, 2022 and July 30, 2021 were as follows: (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of April 29, 2022 $ 34,933 $ 3,899 $ (11,009) $ 27,823 Other comprehensive (income) loss before reclassifications 5,792 — (632) 5,160 Amounts reclassified from AOCL — — (1,840) (1,840) Net current period other comprehensive (income) loss 5,792 — (2,472) 3,320 Balance as of July 29, 2022 $ 40,725 $ 3,899 $ (13,481) $ 31,143 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2021 $ 19,535 $ 3,899 $ 2,562 $ 25,996 Other comprehensive (income) loss before reclassifications 21,190 — (14,448) 6,742 Amounts reclassified from AOCL — — (1,595) (1,595) Net current period other comprehensive (income) loss 21,190 — (16,043) 5,147 Balance as of July 29, 2022 $ 40,725 $ 3,899 $ (13,481) $ 31,143 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of April 30, 2021 $ 12,509 $ 5,106 $ 11,797 $ 29,412 Other comprehensive (income) loss before reclassifications 5,314 — (11,117) (5,803) Amounts reclassified from AOCL — — 3,082 3,082 Net current period other comprehensive (income) 5,314 — (8,035) (2,721) Balance as of July 30, 2021 $ 17,823 $ 5,106 $ 3,762 $ 26,691 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2020 $ 24,508 $ 5,106 $ 4,648 $ 34,262 Other comprehensive income before reclassifications (6,685) — (10,151) (16,836) Amounts reclassified from AOCL — — 9,265 9,265 Net current period other comprehensive income (6,685) — (886) (7,571) Balance as of July 30, 2021 $ 17,823 $ 5,106 $ 3,762 $ 26,691 For additional information on the components reclassified from AOCL to the respective line items in net earnings for derivative instruments refer to Note 16, Derivative Instruments and Hedging Activities .

Per Share Data

Per Share Data	9 Months Ended
	Jul. 29, 2022
Earnings Per Share [Abstract]
Per Share Data	13 Per Share Data Reconciliations of basic and diluted weighted-average number of shares of common stock outstanding were as follows: Three Months Ended Nine Months Ended (Shares in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Basic Weighted-average number of shares of common stock 104,827 107,130 104,924 107,661 Assumed issuance of contingent shares — — 7 6 Weighted-average number of shares of common stock outstanding - Basic 104,827 107,130 104,931 107,667 Diluted Weighted-average number of shares of common stock outstanding - Basic 104,827 107,130 104,931 107,667 Effect of dilutive shares 621 1,233 823 1,151 Weighted-average number of shares of common stock outstanding - Diluted 105,448 108,363 105,754 108,818

Contingencies

Contingencies	9 Months Ended
	Jul. 29, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	14 Contingencies Litigation From time to time, the company is party to litigation in the ordinary course of business. Such matters are generally subject to uncertainties and to outcomes that are not predictable with assurance and that may not be known for extended periods of time. Litigation occasionally involves claims for punitive, as well as compensatory, damages arising out of the use of the company’s products. Although the company is self-insured to some extent, the company maintains insurance against certain product liability losses. The company is also subject to litigation and administrative and judicial proceedings with respect to claims involving asbestos and the discharge of hazardous substances into the environment. Some of these claims assert damages and liability for personal injury, remedial investigations or clean-up and other costs and damages. The company is also occasionally involved in commercial disputes, employment or employment-related disputes, and patent litigation cases in which it is asserting or defending against patent infringement claims. To prevent possible infringement of the company’s patents by others, the company periodically reviews competitors’ products. To avoid potential liability with respect to others’ patents, the company reviews certain patents issued by the U.S. Patent and Trademark Office and foreign patent offices. The company believes these activities help minimize its risk of being a defendant in patent infringement litigation. The company records a liability in its Condensed Consolidated Financial Statements for costs related to claims, including future legal costs, settlements, and judgments, where the company has assessed that a loss is probable and an amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. The company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred. In the opinion of management, the amount of liability, if any, with respect to these matters, individually or in the aggregate, will not materially affect the company's consolidated results of operations, financial position, or cash flows. In situations where the company receives, or expects to receive, a favorable ruling related to a litigation settlement, the company follows the accounting standards codification guidance for gain contingencies. The company does not allow for the recognition of a gain contingency within its Condensed Consolidated Financial Statements prior to the settlement of the underlying events or contingencies associated with the gain contingency. As a result, the consideration related to a gain contingency is recorded in the Condensed Consolidated Financial Statements during the period in which all underlying events or contingencies are resolved and the gain is realized. Litigation Settlement On November 19, 2020, Exmark Manufacturing Company Incorporated ("Exmark"), a wholly-owned subsidiary of the company, and Briggs & Stratton Corporation (“BGG”) entered into a settlement agreement (“Settlement Agreement”) relating to the decade-long patent infringement litigation that Exmark originally filed in May 2010 against Briggs & Stratton Power Products Group, LLC (“BSPPG”), a former wholly-owned subsidiary of BGG (Case No. 8:10CV187, U.S. District Court for the District of Nebraska) (the “Infringement Action”). In the Infringement Action, Exmark alleged that certain mower decks manufactured by BSPPG infringed an Exmark mower deck patent. Despite favorable judgments in the Infringement Action in favor of Exmark, including with regard to awarded damages, actions by BGG during the second half of calendar year 2020 put in jeopardy the certainty and timing of the eventual receipt of the damages awarded to Exmark in the Infringement Action, including (i) the filing by BGG and certain of its subsidiaries for bankruptcy relief under chapter 11 of title 11 of the United States Bankruptcy Code (“BGG Bankruptcy”); (ii) the sale of substantially all the assets (but not certain liabilities, including the Infringement Action) of BGG and its subsidiaries to a third-party pursuant to Section 363 of the United States Bankruptcy Code; and (iii) a petition filed by BGG for a panel rehearing of the United States Court of Appeals for the Federal Circuit's decision in the Infringement Action (“Rehearing Petition”). As a result, on November 19, 2020, Exmark entered into the Settlement Agreement with BGG which provided, among other things, that (i) upon approval by the bankruptcy court, and such approval becoming final and nonappealable, BGG agreed to pay Exmark $33.65 million (“Settlement Amount”), (ii) BGG agreed to immediately withdraw the Rehearing Petition and otherwise not pursue additional appellate review regarding the Infringement Action, and (iii) after receipt of the Settlement Amount, Exmark agreed to release a supersedeas appeal bond that had been obtained by BGG to support payment of the damages awarded to Exmark in the Infringement Action. On November 20, 2020, BGG filed a motion to withdraw the Rehearing Petition and on December 16, 2020, the bankruptcy court approved the Settlement Agreement. During January 2021, the first quarter of fiscal 2021, the Settlement Amount was received by Exmark in connection with the settlement of the Infringement Action and at such time, the underlying events and contingencies associated with the gain contingency related to the Infringement Action were satisfied. As such, the company recognized in selling, general and administrative expense within the Condensed Consolidated Statements of Earnings during the first quarter of fiscal 2021 (i) the gain associated with the Infringement Action and (ii) a corresponding expense related to the contingent fee arrangement with the company's external legal counsel customary in patent infringement cases equal to approximately 50 percent of the Settlement Amount.

Leases

Leases	9 Months Ended
	Jul. 29, 2022
Leases [Abstract]
Leases	15 Leases The company enters into contracts that are, or contain, operating lease agreements for certain property, plant, or equipment assets utilized in the normal course of business, such as buildings for manufacturing facilities, office space, distribution centers, and warehouse facilities; land for product testing sites; machinery and equipment for research and development activities, manufacturing and assembly processes, and administrative tasks; and vehicles for sales, service, marketing, and distribution activities. Contracts that explicitly or implicitly relate to property, plant, and equipment are assessed at inception to determine if the contract is, or contains, a lease. Such contracts for operating lease agreements convey the company's right to direct the use of, and obtain substantially all of the economic benefits from, an identified asset for a defined period of time in exchange for consideration. The lease term begins and is determined upon lease commencement, which is the point in time when the company takes possession of the identified asset, and generally includes all non-cancelable periods. Lease expense for the company's operating leases is recognized on a straight-line basis over the lease term and is recorded within cost of sales or selling, general and administrative expense within the Condensed Consolidated Statements of Earnings as dictated by the nature and use of the underlying asset. The company does not recognize right-of-use assets and lease liabilities, but does recognize expense on a straight-line basis, for short-term operating leases which have a lease term of 12 months or less and do not include an option to purchase the underlying asset. Lease payments are determined at lease commencement and generally represent fixed lease payments as defined within the respective lease agreement or, in the case of certain lease agreements, variable lease payments that are measured as of the lease commencement date based on the prevailing index or market rate. Future adjustments to variable lease payments are defined and scheduled within the respective lease agreement and are determined based upon the prevailing market or index rate at the time of the adjustment relative to the market or index rate determined at lease commencement. Certain other lease agreements contain variable lease payments that are determined based upon actual utilization of the identified asset. Such future adjustments to variable lease payments and variable lease payments based upon actual utilization of the identified asset are not included within the determination of lease payments at commencement but rather, are recorded as variable lease expense in the period in which the variable lease cost is incurred. Right-of-use assets represent the company's right to use an underlying asset throughout the lease term and lease liabilities represent the company's obligation to make lease payments arising from the lease agreement. The company accounts for operating lease liabilities at lease commencement and on an ongoing basis as the present value of the minimum remaining lease payments under the respective lease term. Minimum remaining lease payments are generally discounted to present value based the estimated incremental borrowing rate at lease commencement as the rate implicit in the lease is generally not readily determinable. Right-of-use assets are measured as the amount of the corresponding operating lease liability for the respective operating lease agreement, adjusted for prepaid or accrued lease payments, the remaining balance of any lease incentives received, unamortized initial direct costs, and impairment of the operating lease right-of-use asset, as applicable. The following table presents the lease expense incurred on the company’s operating, short-term, and variable leases: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Operating lease expense $ 3,833 $ 4,397 $ 16,304 $ 14,488 Short-term lease expense 303 256 3,445 1,693 Variable lease expense 12 22 12 72 Total lease expense $ 4,148 $ 4,675 $ 19,761 $ 16,253 The following table presents supplemental cash flow information related to the company's operating leases: Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 Operating cash flows for amounts included in the measurement of lease liabilities $ 14,129 $ 14,288 Right-of-use assets obtained in exchange for lease obligations $ 18,236 $ 4,739 The following table presents other lease information related to the company's operating leases: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Weighted-average remaining lease term of operating leases in years 6.2 6.6 6.6 Weighted-average discount rate of operating leases 2.99 % 2.70 % 2.71 % The following table reconciles the total undiscounted future cash flows based on the anticipated future minimum operating lease payments by fiscal year for the company's operating leases to the present value of operating lease liabilities recorded within the Condensed Consolidated Balance Sheets as of July 29, 2022: (Dollars in thousands) July 29, 2022 2022 (remaining) $ 4,579 2023 17,540 2024 16,164 2025 14,001 2026 8,819 Thereafter 24,086 Total future minimum operating lease payments 85,189 Less: imputed interest 8,593 Present value of operating lease liabilities $ 76,596

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Jul. 29, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	16 Derivative Instruments and Hedging Activities Risk Management Objective of Using Derivatives The company is exposed to foreign currency exchange rate risk arising from transactions in the normal course of business, such as sales to third-party customers, sales and loans to wholly-owned foreign subsidiaries, costs associated with foreign plant operations, and purchases from suppliers. The company’s primary currency exchange rate exposures are with the Euro, the Australian dollar, the Canadian dollar, the British pound, the Mexican peso, the Japanese yen, the Chinese Renminbi, and the Romanian New Leu against the U.S. dollar, as well as the Romanian New Leu against the Euro. To reduce its exposure to foreign currency exchange rate risk, the company enters into various derivative instruments to hedge against such risk, authorized under a company policy that places controls on these hedging activities, with counterparties that are highly rated financial institutions. The company’s policy does not allow the use of derivative instruments for trading or speculative purposes. The company has also made an accounting policy election to use the portfolio exception with respect to measuring counterparty credit risk for derivative instruments and to measure the fair value of a portfolio of financial assets and financial liabilities on the basis of the net open risk position with each counterparty. The company’s hedging activities primarily involve the use of forward currency contracts to hedge most foreign currency transactions, including forecasted sales and purchases denominated in foreign currencies. The company uses derivative instruments only in an attempt to limit underlying exposure from foreign currency exchange rate fluctuations and to minimize earnings and cash flow volatility associated with foreign currency exchange rate fluctuations. Decisions on whether to use such derivative instruments are primarily based on the amount of exposure to the currency involved and an assessment of the near-term market value for each currency. The company recognizes all derivative instruments at fair value on the Condensed Consolidated Balance Sheets as either assets or liabilities. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as a cash flow hedging instrument. Cash Flow Hedging Instruments The company formally documents relationships between cash flow hedging instruments and the related hedged transactions, as well as its risk-management objective and strategy for undertaking cash flow hedging instruments. This process includes linking all cash flow hedging instruments to the forecasted transactions, such as sales to third-parties and costs associated with foreign plant operations, including purchases from suppliers. At the cash flow hedge’s inception and on an ongoing basis, the company formally assesses whether the cash flow hedging instruments have been highly effective in offsetting changes in the cash flows of the hedged transactions and whether those cash flow hedging instruments may be expected to remain highly effective in future periods. Changes in the fair values of the spot rate component of outstanding, highly effective cash flow hedging instruments included in the assessment of hedge effectiveness are recorded in other comprehensive income within AOCL on the Condensed Consolidated Balance Sheets and are subsequently reclassified to net earnings within the Condensed Consolidated Statements of Earnings during the same period in which the cash flows of the underlying hedged transaction affect net earnings. Changes in the fair values of hedge components excluded from the assessment of effectiveness are recognized immediately in net earnings under the mark-to-market approach. The classification of gains or losses recognized on cash flow hedging instruments and excluded components within the Condensed Consolidated Statements of Earnings is the same as that of the underlying exposure. Results of cash flow hedging instruments, and the related excluded components, of sales and costs associated with foreign plant operations, including purchases from suppliers, are recorded in net sales and cost of sales, respectively. The maximum amount of time the company hedges its exposure to the variability in future cash flows for forecasted trade sales and purchases is two years. When it is determined that a derivative instrument is not, or has ceased to be, highly effective as a cash flow hedge, the company discontinues cash flow hedge accounting prospectively. The gain or loss on the dedesignated derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. When the company discontinues cash flow hedge accounting because it is no longer probable, but it is still reasonably possible that the forecasted transaction will occur by the end of the originally expected period or within an additional two-month period of time thereafter, the gain or loss on the derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. However, if it is probable that a forecasted transaction will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter, the gains and losses that were in AOCL are immediately recognized in net earnings within other income, net in the Condensed Consolidated Statements of Earnings. In all situations in which cash flow hedge accounting is discontinued and the derivative instrument remains outstanding, the company carries the derivative instrument at its fair value on the Condensed Consolidated Balance Sheets, recognizing future changes in the fair value within other income, net in the Condensed Consolidated Statements of Earnings. As of July 29, 2022, the notional amount outstanding of forward currency contracts designated as cash flow hedging instruments was $293.0 million. Derivatives Not Designated as Cash Flow Hedging Instruments The company also enters into foreign currency contracts that include forward currency contracts to mitigate the remeasurement of specific assets and liabilities on the Condensed Consolidated Balance Sheets. These contracts are not designated as cash flow hedging instruments. Accordingly, changes in the fair value of hedges of recorded balance sheet positions, such as cash, receivables, payables, intercompany notes, and other various contractual claims to pay or receive foreign currencies other than the functional currency, are recognized immediately in other income, net, on the Condensed Consolidated Statements of Earnings together with the transaction gain or loss from the hedged balance sheet position. The following table presents the fair value and location of the company’s derivative instruments on the Condensed Consolidated Balance Sheets: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Derivative assets: Derivatives designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts $ 17,723 $ 1,235 $ 189 Derivatives not designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts 4,618 309 133 Total derivative assets $ 22,341 $ 1,544 $ 322 Derivative liabilities: Derivatives designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts $ — $ 3,682 $ 1,260 Derivatives not designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts 18 1,554 872 Total derivative liabilities $ 18 $ 5,236 $ 2,132 The company entered into an International Swap Dealers Association ("ISDA") Master Agreement with each counterparty that permits the net settlement of amounts owed under their respective contracts. The ISDA Master Agreement is an industry standardized contract that governs all derivative contracts entered into between the company and the respective counterparty. Under these master netting agreements, net settlement generally permits the company or the counterparty to determine the net amount payable or receivable for contracts due on the same date or in the same currency for similar types of derivative transactions. The company records the fair value of its derivative instruments at the net amount on its Condensed Consolidated Balance Sheets. The following table presents the effects of the master netting arrangements on the fair value of the company’s derivative instruments that are recorded on the Condensed Consolidated Balance Sheets: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Derivative assets: Forward currency contracts: Gross amount of derivative assets $ 22,424 $ 1,544 $ 423 Derivative liabilities offsetting derivative assets 83 — 101 Net amount of derivative assets $ 22,341 $ 1,544 $ 322 Derivative liabilities: Forward currency contracts: Gross amount of derivative liabilities $ 18 $ 5,849 $ 4,853 Derivative assets offsetting derivative liabilities — 613 2,721 Net amount of derivative liabilities $ 18 $ 5,236 $ 2,132 The following table presents the impact and location of the amounts reclassified from AOCL into net earnings on the Condensed Consolidated Statements of Earnings and the impact of derivative instruments on the Condensed Consolidated Statements of Comprehensive Income for the company's derivatives designated as cash flow hedging instruments for the three and nine months ended July 29, 2022 and July 30, 2021: Three Months Ended Gain (Loss) Reclassified from AOCL into Earnings Gain (Loss) Recognized in OCI on Derivatives (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Derivatives designated as cash flow hedging instruments: Forward currency contracts: Net sales $ 1,640 $ (3,113) $ 2,508 $ 7,350 Cost of sales 200 31 (36) 685 Total derivatives designated as cash flow hedging instruments $ 1,840 $ (3,082) $ 2,472 $ 8,035 Nine Months Ended Gain (Loss) Reclassified from AOCL into Earnings Gain Recognized in OCI on Derivatives (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Derivatives designated as cash flow hedging instruments: Forward currency contracts: Net sales $ 1,431 $ (9,325) $ 14,836 $ 620 Cost of sales 164 60 1,207 266 Total derivatives designated as cash flow hedging instruments $ 1,595 $ (9,265) $ 16,043 $ 886 The company recognized immaterial gains within other income, net in the Condensed Consolidated Statements of Earnings during the third quarter and first nine months of fiscal 2022, and recognized immaterial losses within other income, net in the Condensed Consolidated Statements of Earnings during third quarter and first nine months of fiscal 2021, respectively, due to the discontinuance of cash flow hedge accounting on certain forward currency contracts designated as cash flow hedging instruments. As of July 29, 2022, the company expects to reclassify approximately $12.4 million of gains from AOCL to earnings during the next twelve months. The following tables present the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives designated as cash flow hedging instruments and the related components excluded from effectiveness testing: Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments (Dollars in thousands) July 29, 2022 July 30, 2021 Three Months Ended Net Sales Cost of Sales Net Sales Cost of Sales Condensed Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded $ 1,160,550 $ (760,644) $ 976,836 $ (645,719) Gain (loss) on derivatives designated as cash flow hedging instruments: Forward currency contracts: Amount of gain (loss) reclassified from AOCL into earnings 1,640 200 (3,113) 31 Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 646 $ 627 $ 322 $ 70 Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments (Dollars in thousands) July 29, 2022 July 30, 2021 Nine Months Ended Net Sales Cost of Sales Net Sales Cost of Sales Condensed Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded $ 3,342,678 $ (2,236,927) $ 2,998,929 $ (1,949,823) Gain (loss) on derivatives designated as cash flow hedging instruments: Forward currency contracts: Amount of gain (loss) reclassified from AOCL into earnings 1,431 164 (9,325) 60 Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ (930) $ 1,180 $ 784 $ 366 The following table presents the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives not designated as cash flow hedging instruments: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Gain (loss) on derivatives not designated as cash flow hedging instruments Forward currency contracts: Other income, net $ (344) $ 1,972 $ 3,639 $ (4,511) Total gain (loss) on derivatives not designated as cash flow hedging instruments $ (344) $ 1,972 $ 3,639 $ (4,511)

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jul. 29, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	17 Fair Value Measurements The company categorizes its assets and liabilities into one of three levels based on the assumptions (inputs) used in valuing the asset or liability. Estimates of fair value for financial assets and financial liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value, and requires certain disclosures. The framework discusses valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flows), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1 : Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 : Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 : Unobservable inputs reflecting management’s assumptions about the inputs used in pricing the asset or liability. Recurring Fair Value Measurements The company's derivative instruments consist of forward currency contracts that are measured at fair value on a recurring basis. The fair value of such forward currency contracts is determined based on observable market transactions of forward currency prices and spot currency rates as of the reporting date. The following tables present, by level within the fair value hierarchy, the company's financial assets and liabilities that are measured at fair value on a recurring basis as of July 29, 2022, July 30, 2021, and October 31, 2021, according to the valuation technique utilized to determine their fair values (in thousands): Fair Value Measurements Using Inputs Considered as: July 29, 2022 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 22,341 $ — $ 22,341 $ — Total assets $ 22,341 $ — $ 22,341 $ — Liabilities: Forward currency contracts $ 18 $ — $ 18 $ — Total liabilities $ 18 $ — $ 18 $ — Fair Value Measurements Using Inputs Considered as: July 30, 2021 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 1,544 $ — $ 1,544 $ — Total assets $ 1,544 $ — $ 1,544 $ — Liabilities: Forward currency contracts $ 5,236 $ — $ 5,236 $ — Total liabilities $ 5,236 $ — $ 5,236 $ — Fair Value Measurements Using Inputs Considered as: October 31, 2021 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 322 $ — $ 322 $ — Total assets $ 322 $ — $ 322 $ — Liabilities: Forward currency contracts $ 2,132 $ — $ 2,132 $ — Total liabilities $ 2,132 $ — $ 2,132 $ — Nonrecurring Fair Value Measurements The company measures certain assets and liabilities at fair value on a non-recurring basis. Assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets, goodwill, and indefinite-lived intangible assets, which would generally be recorded at fair value as a result of an impairment charge. Assets acquired and liabilities assumed as part of a business combination or asset acquisition are also measured at fair value on a non-recurring basis during the measurement period allowed by the accounting standards codification guidance for business combinations and asset acquisitions, when applicable. For additional information on the company's business combination and the related non-recurring fair value measurement of the assets acquired and liabilities assumed, refer to Note 2, Business Combinations and Asset Acquisitions . Other Fair Value Disclosures The carrying values of the company's short-term financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and short-term debt, including current maturities of long-term debt, when applicable, approximate their fair values due to their short-term nature. As of July 29, 2022, July 30, 2021 and October 31, 2021, the company's long-term debt included $524.1 million, $424.0 million and $424.0 million of gross fixed-rate debt that is not subject to variable interest rate fluctuations. The gross fair value of such long-term debt is determined using Level 2 inputs by discounting the projected cash flows based on quoted market rates at which similar amounts of debt could currently be borrowed. As of July 29, 2022, the estimated gross fair value of long-term debt with fixed interest rates was $541.0 million compared to its gross carrying amount of $524.1 million. As of July 30, 2021, the estimated gross fair value of long-term debt with fixed interest rates was $525.9 million compared to its gross carrying amount of $424.0 million. As of October 31, 2021, the estimated gross fair value of long-term debt with fixed interest rates was $517.9 million compared to its gross carrying amount of $424.0 million. For additional information regarding long-term debt with fixed interest rates, refer to Note 6, Indebtedness.

Subsequent Events

Subsequent Events	9 Months Ended
	Jul. 29, 2022
Subsequent Events [Abstract]
Subsequent Events	18 Subsequent Events The company has evaluated all subsequent events and concluded that no subsequent events have occurred that would require recognition in the Condensed Consolidated Financial Statements or disclosure in the Notes to the Condensed Consolidated Financial Statements.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Jul. 29, 2022
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States ("U.S.") generally accepted accounting principles ("GAAP") for complete financial statements. Unless the context indicates otherwise, the terms "company," "TTC," "we," "our," or "us" refer to The Toro Company and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated from the unaudited Condensed Consolidated Financial Statements.In the opinion of management, the unaudited Condensed Consolidated Financial Statements include all adjustments, consisting primarily of recurring accruals, considered necessary for the fair presentation of the company's consolidated financial position, results of operations, and cash flows for the periods presented.
Fiscal Period	The company’s fiscal year ends on October 31 and quarterly results are reported based on three-month periods that generally end on the Friday closest to the calendar quarter end. For comparative purposes, however, the company’s second and third quarters always include exactly 13 weeks of results so that the quarter end date for these two quarters is not necessarily the Friday closest to the calendar month end. For further information regarding the company's basis of presentation, refer to the Consolidated Financial Statements and Notes to Consolidated Financial Statements included in the company’s Annual Report on Form 10-K for the fiscal year ended
Accounting Policies and Estimates	Accounting Policies and Estimates In preparing the Condensed Consolidated Financial Statements in conformity with U.S. GAAP, management must make decisions that impact the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures, including disclosures of contingent assets and liabilities. Such decisions include the selection of the appropriate accounting principles to be applied and the assumptions on which to base accounting estimates. Estimates are used in determining, among other items, sales promotion and incentive accruals, incentive compensation accruals, income tax accruals, inventory valuation, warranty accruals, allowances for current expected credit losses, pension accruals, self-insurance accruals, legal accruals, right-of-use assets and lease liabilities, useful lives for tangible and finite-lived intangible assets, future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, and valuations of the assets acquired and liabilities assumed in a business combination or an asset acquisition, when applicable. These estimates and assumptions are based on management’s best estimates and judgments at the time they are made and are generally derived from management's understanding and analysis of the relevant and current circumstances, historical experience, and actuarial and other independent external third-party specialist valuations, when applicable. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors that management believes to be reasonable under
New Accounting Pronouncements Adopted and New Accounting Pronouncements Not Yet Adopted	New Accounting Pronouncements Adopted In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The amended guidance also clarifies and simplifies other aspects of the accounting for income taxes under accounting standards codification Topic 740, Income Taxes . The amended guidance was adopted in the first quarter of fiscal 2022 and did not have a material impact on the company's Condensed Consolidated Financial Statements. In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) , which clarified that before applying or upon discontinuing the equity method of accounting for an investment in equity securities, an entity should consider observable transactions that require it to apply or discontinue the equity method of accounting for the purposes of applying the fair value measurement alternative. The amended guidance was adopted in the first quarter of fiscal 2022 and did not have a material impact on the company's Condensed Consolidated Financial Statements. New Accounting Pronouncements Not Yet Adopted In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides temporary optional guidance to ease the potential burden of accounting for reference rate reform due to the cessation of the London Interbank Offered Rate, commonly referred to as "LIBOR." The temporary guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, relationships, and transactions affected by reference rate reform if certain criteria are met. The guidance was effective upon issuance on March 12, 2020 and the provisions of the temporary optional guidance provided by the ASU may be elected on a prospective basis from the beginning of an interim period that includes the issuance date of the ASU through December 31, 2022, when the reference rate reform activity is expected to be substantially complete. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope , to provide supplemental guidance and to further clarify the scope of the amended guidance. At this time, the company does not have receivables, hedging relationships, or operating lease agreements that reference LIBOR or another reference rate expected to be discontinued; and therefore, the company has not applied the optional practical expedients under this ASU to these classes of assets. On October 5, 2021, the company entered into an amended and restated credit agreement and at such time, the company concluded that the optional practical expedients provided by the ASU would not be elected as the required criteria were not met. The amended and restated credit agreement includes a transition clause in the event LIBOR is discontinued and the company's other fixed-rate financing agreements do not reference LIBOR or another reference rate expected to be discontinued. On April 27, 2022, the company amended its October 5, 2021 amended and restated revolving credit agreement to transition the reference rate from LIBOR to Secured Overnight Financing Rate ("SOFR"). As of July 29, 2022, SOFR is the reference rate in effect for all outstanding variable interest borrowings of the company. The company does not expect the transition of LIBOR to have a material impact on the company's Condensed Consolidated Financial Statements; however, a review of other contracts and agreements is underway and is expected to be completed prior to December 31, 2022. The company believes that all other recently issued accounting pronouncements from the FASB that the company has not noted above, will not have a material impact on its Condensed Consolidated Financial Statements or do not apply to its operations.
Inventories, Net	Inventories are valued at the lower of cost or net realizable value, with cost determined by the first-in, first-out ("FIFO") and average cost methods for a majority of the company's inventories. All remaining inventories are valued at the lower of cost or market, with cost determined under the last-in, first-out ("LIFO") method. As needed, the company records an inventory valuation adjustment for excess, slow-moving, and obsolete inventory that is equal to the excess of the cost of the inventory over the estimated net realizable value or market value for the inventory depending on the inventory costing method. Such inventory valuation adjustment is based on a review and comparison of current inventory levels to planned production, as well as planned and historical sales of the inventory. The inventory valuation adjustment to net realizable value or market value establishes a new cost basis of the inventory that cannot be subsequently reversed.
Leases	The company enters into contracts that are, or contain, operating lease agreements for certain property, plant, or equipment assets utilized in the normal course of business, such as buildings for manufacturing facilities, office space, distribution centers, and warehouse facilities; land for product testing sites; machinery and equipment for research and development activities, manufacturing and assembly processes, and administrative tasks; and vehicles for sales, service, marketing, and distribution activities. Contracts that explicitly or implicitly relate to property, plant, and equipment are assessed at inception to determine if the contract is, or contains, a lease. Such contracts for operating lease agreements convey the company's right to direct the use of, and obtain substantially all of the economic benefits from, an identified asset for a defined period of time in exchange for consideration. The lease term begins and is determined upon lease commencement, which is the point in time when the company takes possession of the identified asset, and generally includes all non-cancelable periods. Lease expense for the company's operating leases is recognized on a straight-line basis over the lease term and is recorded within cost of sales or selling, general and administrative expense within the Condensed Consolidated Statements of Earnings as dictated by the nature and use of the underlying asset. The company does not recognize right-of-use assets and lease liabilities, but does recognize expense on a straight-line basis, for short-term operating leases which have a lease term of 12 months or less and do not include an option to purchase the underlying asset. Lease payments are determined at lease commencement and generally represent fixed lease payments as defined within the respective lease agreement or, in the case of certain lease agreements, variable lease payments that are measured as of the lease commencement date based on the prevailing index or market rate. Future adjustments to variable lease payments are defined and scheduled within the respective lease agreement and are determined based upon the prevailing market or index rate at the time of the adjustment relative to the market or index rate determined at lease commencement. Certain other lease agreements contain variable lease payments that are determined based upon actual utilization of the identified asset. Such future adjustments to variable lease payments and variable lease payments based upon actual utilization of the identified asset are not included within the determination of lease payments at commencement but rather, are recorded as variable lease expense in the period in which the variable lease cost is incurred. Right-of-use assets represent the company's right to use an underlying asset throughout the lease term and lease liabilities represent the company's obligation to make lease payments arising from the lease agreement. The company accounts for operating lease liabilities at lease commencement and on an ongoing basis as the present value of the minimum remaining lease payments under the respective lease term. Minimum remaining lease payments are generally discounted to present value based the estimated incremental borrowing rate at lease commencement as the rate implicit in the lease is generally not readily determinable. Right-of-use assets are measured as the amount of the corresponding operating lease liability for the respective operating lease agreement, adjusted for prepaid or accrued lease payments, the remaining balance of any lease incentives received, unamortized initial direct costs, and impairment of the operating lease right-of-use asset, as applicable.
Derivative Instruments and Hedging Activities	Risk Management Objective of Using Derivatives The company is exposed to foreign currency exchange rate risk arising from transactions in the normal course of business, such as sales to third-party customers, sales and loans to wholly-owned foreign subsidiaries, costs associated with foreign plant operations, and purchases from suppliers. The company’s primary currency exchange rate exposures are with the Euro, the Australian dollar, the Canadian dollar, the British pound, the Mexican peso, the Japanese yen, the Chinese Renminbi, and the Romanian New Leu against the U.S. dollar, as well as the Romanian New Leu against the Euro. To reduce its exposure to foreign currency exchange rate risk, the company enters into various derivative instruments to hedge against such risk, authorized under a company policy that places controls on these hedging activities, with counterparties that are highly rated financial institutions. The company’s policy does not allow the use of derivative instruments for trading or speculative purposes. The company has also made an accounting policy election to use the portfolio exception with respect to measuring counterparty credit risk for derivative instruments and to measure the fair value of a portfolio of financial assets and financial liabilities on the basis of the net open risk position with each counterparty. The company’s hedging activities primarily involve the use of forward currency contracts to hedge most foreign currency transactions, including forecasted sales and purchases denominated in foreign currencies. The company uses derivative instruments only in an attempt to limit underlying exposure from foreign currency exchange rate fluctuations and to minimize earnings and cash flow volatility associated with foreign currency exchange rate fluctuations. Decisions on whether to use such derivative instruments are primarily based on the amount of exposure to the currency involved and an assessment of the near-term market value for each currency. The company recognizes all derivative instruments at fair value on the Condensed Consolidated Balance Sheets as either assets or liabilities. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as a cash flow hedging instrument. Cash Flow Hedging Instruments The company formally documents relationships between cash flow hedging instruments and the related hedged transactions, as well as its risk-management objective and strategy for undertaking cash flow hedging instruments. This process includes linking all cash flow hedging instruments to the forecasted transactions, such as sales to third-parties and costs associated with foreign plant operations, including purchases from suppliers. At the cash flow hedge’s inception and on an ongoing basis, the company formally assesses whether the cash flow hedging instruments have been highly effective in offsetting changes in the cash flows of the hedged transactions and whether those cash flow hedging instruments may be expected to remain highly effective in future periods. Changes in the fair values of the spot rate component of outstanding, highly effective cash flow hedging instruments included in the assessment of hedge effectiveness are recorded in other comprehensive income within AOCL on the Condensed Consolidated Balance Sheets and are subsequently reclassified to net earnings within the Condensed Consolidated Statements of Earnings during the same period in which the cash flows of the underlying hedged transaction affect net earnings. Changes in the fair values of hedge components excluded from the assessment of effectiveness are recognized immediately in net earnings under the mark-to-market approach. The classification of gains or losses recognized on cash flow hedging instruments and excluded components within the Condensed Consolidated Statements of Earnings is the same as that of the underlying exposure. Results of cash flow hedging instruments, and the related excluded components, of sales and costs associated with foreign plant operations, including purchases from suppliers, are recorded in net sales and cost of sales, respectively. The maximum amount of time the company hedges its exposure to the variability in future cash flows for forecasted trade sales and purchases is two years. When it is determined that a derivative instrument is not, or has ceased to be, highly effective as a cash flow hedge, the company discontinues cash flow hedge accounting prospectively. The gain or loss on the dedesignated derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. When the company discontinues cash flow hedge accounting because it is no longer probable, but it is still reasonably possible that the forecasted transaction will occur by the end of the originally expected period or within an additional two-month period of time thereafter, the gain or loss on the derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. However, if it is probable that a forecasted transaction will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter, the gains and losses that were in AOCL are immediately recognized in net earnings within other income, net in the Condensed Consolidated Statements of Earnings. In all situations in which cash flow hedge accounting is discontinued and the derivative instrument remains outstanding, the company carries the derivative instrument at its fair value on the Condensed Consolidated Balance Sheets, recognizing future changes in the fair value within other income, net in the Condensed Consolidated Statements of Earnings. As of July 29, 2022, the notional amount outstanding of forward currency contracts designated as cash flow hedging instruments was $293.0 million. Derivatives Not Designated as Cash Flow Hedging Instruments The company also enters into foreign currency contracts that include forward currency contracts to mitigate the remeasurement of specific assets and liabilities on the Condensed Consolidated Balance Sheets. These contracts are not designated as cash flow hedging instruments. Accordingly, changes in the fair value of hedges of recorded balance sheet positions, such as cash, receivables, payables, intercompany notes, and other various contractual claims to pay or receive foreign currencies other than the functional currency, are recognized immediately in other income, net, on the Condensed Consolidated Statements of Earnings together with the transaction gain or loss from the hedged balance sheet position.
Fair Value Measurements	The company categorizes its assets and liabilities into one of three levels based on the assumptions (inputs) used in valuing the asset or liability. Estimates of fair value for financial assets and financial liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value, and requires certain disclosures. The framework discusses valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flows), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1 : Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 : Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 : Unobservable inputs reflecting management’s assumptions about the inputs used in pricing the asset or liability. Recurring Fair Value Measurements The company's derivative instruments consist of forward currency contracts that are measured at fair value on a recurring basis. The fair value of such forward currency contracts is determined based on observable market transactions of forward currency prices and spot currency rates as of the reporting date. Nonrecurring Fair Value Measurements The company measures certain assets and liabilities at fair value on a non-recurring basis. Assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets, goodwill, and indefinite-lived intangible assets, which would generally be recorded at fair value as a result of an impairment charge. Assets acquired and liabilities assumed as part of a business combination or asset acquisition are also measured at fair value on a non-recurring basis during the measurement period allowed by the accounting standards codification guidance for business combinations and asset acquisitions, when applicable. For additional information on the company's business combination and the related non-recurring fair value measurement of the assets acquired and liabilities assumed, refer to Note 2, Business Combinations and Asset Acquisitions . Other Fair Value Disclosures The carrying values of the company's short-term financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and short-term debt, including current maturities of long-term debt, when applicable, approximate

Business Combinations and Ass_2

Business Combinations and Asset Acquisitions (Tables)	9 Months Ended
	Jul. 29, 2022
Business Combination and Asset Acquisition [Abstract]
Summary of Allocation of Preliminary Purchase Price Assigned to Intimidator Group	The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed. These fair values are based on internal company and independent external third-party valuations and are subject to change as certain asset and liability valuations are finalized: (Dollars in thousands) January 13, 2022 Cash and cash equivalents $ 975 Receivables 6,954 Inventories 34,608 Prepaid expenses and other current assets 513 Property, plant and equipment 27,447 Right-of-use assets 344 Goodwill 163,731 Other intangible assets: Indefinite-lived trade name 99,100 Finite-lived trade names 3,260 Finite-lived customer-related 80,500 Finite-lived backlog 1,340 Accounts payable (8,535) Accrued liabilities (9,152) Short-term lease liabilities (100) Long-term lease liabilities (244) Total fair value of net assets acquired 400,741 Less: cash and cash equivalents acquired (975) Total purchase price $ 399,766

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
	Jul. 29, 2022
Segment Reporting [Abstract]
Summarized Financial Information Concerning Reportable Segments	The following tables present summarized financial information concerning the company’s reportable business segments and Other activities (in thousands): Three Months Ended July 29, 2022 Professional Residential Other Total Net sales $ 886,232 $ 269,962 $ 4,356 $ 1,160,550 Intersegment gross sales (eliminations) 10,436 15 (10,451) — Earnings (loss) before income taxes $ 166,191 $ 26,348 $ (35,448) $ 157,091 Nine Months Ended July 29, 2022 Professional Residential Other Total Net sales $ 2,484,927 $ 845,039 $ 12,712 $ 3,342,678 Intersegment gross sales (eliminations) 23,201 50 (23,251) — Earnings (loss) before income taxes 424,833 95,203 (110,742) 409,294 Total assets $ 2,625,481 $ 407,218 $ 407,250 $ 3,439,949 Three Months Ended July 30, 2021 Professional Residential Other Total Net sales $ 718,477 $ 252,117 $ 6,242 $ 976,836 Intersegment gross sales (eliminations) 8,241 13 (8,254) — Earnings (loss) before income taxes $ 122,331 $ 31,548 $ (36,428) $ 117,451 Nine Months Ended July 30, 2021 Professional Residential Other Total Net sales $ 2,197,058 $ 784,852 $ 17,019 $ 2,998,929 Intersegment gross sales (eliminations) 24,034 39 (24,073) — Earnings (loss) before income taxes 406,279 109,642 (85,401) 430,520 Total assets $ 1,949,681 $ 327,064 $ 691,304 $ 2,968,049
Summary of Components of Loss Before Income Taxes Included in Other Segment	The following table presents the details of operating loss before income taxes for the company's Other activities: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Corporate expenses $ (30,816) $ (33,797) $ (94,359) $ (78,814) Interest expense (9,182) (7,016) (24,219) (21,662) Earnings from wholly-owned domestic distribution companies and other income, net 4,550 4,385 7,836 15,075 Total operating loss $ (35,448) $ (36,428) $ (110,742) $ (85,401)

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Jul. 29, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following tables disaggregate the company's reportable segment net sales by major product type and geographic market (in thousands): Three Months Ended July 29, 2022 Professional Residential Other Total Revenue by product type: Equipment $ 780,738 $ 265,469 $ 1,102 $ 1,047,309 Irrigation 105,494 4,493 3,254 113,241 Total net sales $ 886,232 $ 269,962 $ 4,356 $ 1,160,550 Revenue by geographic market: United States $ 710,386 $ 229,666 $ 4,356 $ 944,408 International countries 175,846 40,296 — 216,142 Total net sales $ 886,232 $ 269,962 $ 4,356 $ 1,160,550 Nine Months Ended July 29, 2022 Professional Residential Other Total Revenue by product type: Equipment $ 2,149,549 $ 823,536 $ 6,207 $ 2,979,292 Irrigation 335,378 21,503 6,505 363,386 Total net sales $ 2,484,927 $ 845,039 $ 12,712 $ 3,342,678 Revenue by geographic market: United States $ 1,969,933 $ 703,234 $ 12,712 $ 2,685,879 International countries 514,994 141,805 — 656,799 Total net sales $ 2,484,927 $ 845,039 $ 12,712 $ 3,342,678 Three Months Ended July 30, 2021 Professional Residential Other Total Revenue by product type: Equipment $ 609,022 $ 247,152 $ 3,164 $ 859,338 Irrigation 109,455 4,965 3,078 117,498 Total net sales $ 718,477 $ 252,117 $ 6,242 $ 976,836 Revenue by geographic market: United States $ 559,907 $ 219,022 $ 6,242 $ 785,171 International countries 158,570 33,095 — 191,665 Total net sales $ 718,477 $ 252,117 $ 6,242 $ 976,836 Nine Months Ended July 30, 2021 Professional Residential Other Total Revenue by product type: Equipment $ 1,891,138 $ 761,724 $ 11,436 $ 2,664,298 Irrigation 305,920 23,128 5,583 334,631 Total net sales $ 2,197,058 $ 784,852 $ 17,019 $ 2,998,929 Revenue by geographic market: United States $ 1,681,972 $ 661,017 $ 17,019 $ 2,360,008 International countries 515,086 123,835 — 638,921 Total net sales $ 2,197,058 $ 784,852 $ 17,019 $ 2,998,929

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets, Net (Tables)	9 Months Ended
	Jul. 29, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill by reportable segment for the first nine months of fiscal 2022 were as follows: (Dollars in thousands) Professional Residential Other Total Balance as of October 31, 2021 $ 411,079 $ 10,601 $ — $ 421,680 Goodwill acquired 163,731 — — 163,731 Translation adjustments (1,395) (213) — (1,608) Balance as of July 29, 2022 $ 573,415 $ 10,388 $ — $ 583,803
Schedule of Finite-Lived Intangible Assets	The components of other intangible assets, net as of July 29, 2022, July 30, 2021, and October 31, 2021 were as follows (in thousands): July 29, 2022 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,252 $ (15,178) $ 3,074 Non-compete agreements 5.5 6,887 (6,861) 26 Customer-related 16.0 321,113 (78,017) 243,096 Developed technology 7.1 102,013 (50,412) 51,601 Trade names 13.7 10,689 (3,267) 7,422 Backlog and other 0.6 5,730 (5,280) 450 Total finite-lived 13.4 464,684 (159,015) 305,669 Indefinite-lived - trade names 289,472 — 289,472 Total other intangible assets, net $ 754,156 $ (159,015) $ 595,141 July 30, 2021 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,275 $ (14,482) $ 3,793 Non-compete agreements 5.5 6,908 (6,861) 47 Customer-related 18.2 239,762 (59,017) 180,745 Developed technology 7.0 87,512 (40,943) 46,569 Trade names 15.3 7,544 (2,882) 4,662 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 14.6 364,391 (128,575) 235,816 Indefinite-lived - trade names 190,681 — 190,681 Total other intangible assets, net $ 555,072 $ (128,575) $ 426,497 October 31, 2021 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,283 $ (14,670) $ 3,613 Non-compete agreements 5.5 6,914 (6,872) 42 Customer-related 18.2 239,679 (62,617) 177,062 Developed technology 7.0 87,473 (43,348) 44,125 Trade names 15.4 7,524 (2,969) 4,555 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 14.6 364,263 (134,866) 229,397 Indefinite-lived - trade names 190,644 — 190,644 Total other intangible assets, net $ 554,907 $ (134,866) $ 420,041
Schedule of Indefinite-Lived Intangible Assets	The components of other intangible assets, net as of July 29, 2022, July 30, 2021, and October 31, 2021 were as follows (in thousands): July 29, 2022 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,252 $ (15,178) $ 3,074 Non-compete agreements 5.5 6,887 (6,861) 26 Customer-related 16.0 321,113 (78,017) 243,096 Developed technology 7.1 102,013 (50,412) 51,601 Trade names 13.7 10,689 (3,267) 7,422 Backlog and other 0.6 5,730 (5,280) 450 Total finite-lived 13.4 464,684 (159,015) 305,669 Indefinite-lived - trade names 289,472 — 289,472 Total other intangible assets, net $ 754,156 $ (159,015) $ 595,141 July 30, 2021 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,275 $ (14,482) $ 3,793 Non-compete agreements 5.5 6,908 (6,861) 47 Customer-related 18.2 239,762 (59,017) 180,745 Developed technology 7.0 87,512 (40,943) 46,569 Trade names 15.3 7,544 (2,882) 4,662 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 14.6 364,391 (128,575) 235,816 Indefinite-lived - trade names 190,681 — 190,681 Total other intangible assets, net $ 555,072 $ (128,575) $ 426,497 October 31, 2021 Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,283 $ (14,670) $ 3,613 Non-compete agreements 5.5 6,914 (6,872) 42 Customer-related 18.2 239,679 (62,617) 177,062 Developed technology 7.0 87,473 (43,348) 44,125 Trade names 15.4 7,524 (2,969) 4,555 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 14.6 364,263 (134,866) 229,397 Indefinite-lived - trade names 190,644 — 190,644 Total other intangible assets, net $ 554,907 $ (134,866) $ 420,041

Indebtedness (Tables)

Indebtedness (Tables)	9 Months Ended
	Jul. 29, 2022
Debt Disclosure [Abstract]
Summary of Debt	The following is a summary of the company's indebtedness: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 $600 million revolving credit facility, due October 2026 $ 65,000 $ — $ — $200 million term loan, due April 2022 — 100,000 — $300 million term loan, due April 2024 — 170,000 — $270 million term loan, due October 2026 270,000 — 270,000 $200 million term loan, due April 2027 200,000 — — 3.81% series A senior notes, due June 2029 100,000 100,000 100,000 3.91% series B senior notes, due June 2031 100,000 100,000 100,000 3.97% senior notes, due June 2032 100,000 — — 7.8% debentures, due June 2027 100,000 100,000 100,000 6.625% senior notes, due May 2037 124,086 124,024 124,040 Less: unamortized discounts, debt issuance costs, and deferred charges 3,470 2,462 2,798 Total long-term debt 1,055,616 691,562 691,242 Less: current portion of long-term debt 65,000 104,217 — Long-term debt, less current portion $ 990,616 $ 587,345 $ 691,242

Inventories, Net (Tables)

Inventories, Net (Tables)	9 Months Ended
	Jul. 29, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories, net were as follows: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Raw materials and work in process $ 402,719 $ 280,774 $ 335,325 Finished goods and service parts 672,042 466,961 538,332 Total FIFO and average cost value 1,074,761 747,735 873,657 Less: adjustment to LIFO value 135,487 82,087 135,487 Total inventories, net $ 939,274 $ 665,648 $ 738,170

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	9 Months Ended
	Jul. 29, 2022
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment, net was as follows: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Land and land improvements $ 57,169 $ 56,004 $ 57,690 Buildings and leasehold improvements 326,111 299,484 308,217 Machinery and equipment 535,303 508,383 522,012 Tooling 221,290 233,171 220,966 Computer hardware and software 96,834 102,293 97,485 Construction in process 141,503 82,211 85,722 Property, plant, and equipment, gross 1,378,210 1,281,546 1,292,092 Less: accumulated depreciation 846,394 824,554 804,361 Property, plant, and equipment, net $ 531,816 $ 456,992 $ 487,731

Product Warranty Guarantees (Ta

Product Warranty Guarantees (Tables)	9 Months Ended
	Jul. 29, 2022
Product Warranties Disclosures [Abstract]
Schedule of Changes in Accrued Warranties	The changes in accrued warranties were as follows: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Beginning balance $ 126,830 $ 119,389 $ 116,783 $ 107,121 Provisions 21,824 17,686 62,917 56,204 Acquisitions 2,466 — 5,663 — Claims (20,829) (20,300) (54,601) (51,104) Changes in estimates 727 377 256 4,931 Ending balance $ 131,018 $ 117,152 $ 131,018 $ 117,152

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Jul. 29, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Compensation Cost Related to Stock-Based Awards	Compensation costs related to stock-based compensation awards were as follows: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Stock option awards $ 2,664 $ 2,614 $ 7,207 $ 7,271 Performance share awards 1,697 2,184 5,235 5,205 Restricted stock unit awards 1,611 1,033 4,034 3,029 Unrestricted common stock awards — — 629 671 Total compensation cost for stock-based compensation awards $ 5,972 $ 5,831 $ 17,105 $ 16,176
Schedule of Assumptions for Options Granted	The table below illustrates the weighted-average valuation assumptions used under the Black-Scholes valuation method for options granted in the first nine months of the following fiscal periods: Fiscal 2022 Fiscal 2021 Expected life of option in years 6.19 6.21 Expected stock price volatility 23.74% 23.26% Risk-free interest rate 1.31% 0.55% Expected dividend yield 0.94% 0.86% Per share weighted-average fair value at date of grant $22.55 $19.39

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Jul. 29, 2022
Stockholders' Equity Note [Abstract]
Schedule of Components of Accumulated Other Comprehensive Loss (AOCL), Net of Tax	The components of accumulated other comprehensive loss ("AOCL"), net of tax, within the Condensed Consolidated Statements of Stockholders' Equity were as follows: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Foreign currency translation adjustments $ 40,725 $ 17,823 $ 19,535 Pension benefits 3,899 5,106 3,899 Cash flow derivative instruments (13,481) 3,762 2,562 Total accumulated other comprehensive loss $ 31,143 $ 26,691 $ 25,996
Schedule of Components and Activity of AOCL	The components and activity of AOCL, net of tax, for the three and nine month periods ended July 29, 2022 and July 30, 2021 were as follows: (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of April 29, 2022 $ 34,933 $ 3,899 $ (11,009) $ 27,823 Other comprehensive (income) loss before reclassifications 5,792 — (632) 5,160 Amounts reclassified from AOCL — — (1,840) (1,840) Net current period other comprehensive (income) loss 5,792 — (2,472) 3,320 Balance as of July 29, 2022 $ 40,725 $ 3,899 $ (13,481) $ 31,143 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2021 $ 19,535 $ 3,899 $ 2,562 $ 25,996 Other comprehensive (income) loss before reclassifications 21,190 — (14,448) 6,742 Amounts reclassified from AOCL — — (1,595) (1,595) Net current period other comprehensive (income) loss 21,190 — (16,043) 5,147 Balance as of July 29, 2022 $ 40,725 $ 3,899 $ (13,481) $ 31,143 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of April 30, 2021 $ 12,509 $ 5,106 $ 11,797 $ 29,412 Other comprehensive (income) loss before reclassifications 5,314 — (11,117) (5,803) Amounts reclassified from AOCL — — 3,082 3,082 Net current period other comprehensive (income) 5,314 — (8,035) (2,721) Balance as of July 30, 2021 $ 17,823 $ 5,106 $ 3,762 $ 26,691 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2020 $ 24,508 $ 5,106 $ 4,648 $ 34,262 Other comprehensive income before reclassifications (6,685) — (10,151) (16,836) Amounts reclassified from AOCL — — 9,265 9,265 Net current period other comprehensive income (6,685) — (886) (7,571) Balance as of July 30, 2021 $ 17,823 $ 5,106 $ 3,762 $ 26,691

Per Share Data (Tables)

Per Share Data (Tables)	9 Months Ended
	Jul. 29, 2022
Earnings Per Share [Abstract]
Reconciliations of Basic and Diluted Weighted-Average Shares of Common Stock Outstanding	Reconciliations of basic and diluted weighted-average number of shares of common stock outstanding were as follows: Three Months Ended Nine Months Ended (Shares in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Basic Weighted-average number of shares of common stock 104,827 107,130 104,924 107,661 Assumed issuance of contingent shares — — 7 6 Weighted-average number of shares of common stock outstanding - Basic 104,827 107,130 104,931 107,667 Diluted Weighted-average number of shares of common stock outstanding - Basic 104,827 107,130 104,931 107,667 Effect of dilutive shares 621 1,233 823 1,151 Weighted-average number of shares of common stock outstanding - Diluted 105,448 108,363 105,754 108,818

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jul. 29, 2022
Leases [Abstract]
Supplemental Cash Flow and Other Lease Information	The following table presents the lease expense incurred on the company’s operating, short-term, and variable leases: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Operating lease expense $ 3,833 $ 4,397 $ 16,304 $ 14,488 Short-term lease expense 303 256 3,445 1,693 Variable lease expense 12 22 12 72 Total lease expense $ 4,148 $ 4,675 $ 19,761 $ 16,253 The following table presents supplemental cash flow information related to the company's operating leases: Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 Operating cash flows for amounts included in the measurement of lease liabilities $ 14,129 $ 14,288 Right-of-use assets obtained in exchange for lease obligations $ 18,236 $ 4,739 The following table presents other lease information related to the company's operating leases: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Weighted-average remaining lease term of operating leases in years 6.2 6.6 6.6 Weighted-average discount rate of operating leases 2.99 % 2.70 % 2.71 %
Future Minimum Operating Lease Payments	The following table reconciles the total undiscounted future cash flows based on the anticipated future minimum operating lease payments by fiscal year for the company's operating leases to the present value of operating lease liabilities recorded within the Condensed Consolidated Balance Sheets as of July 29, 2022: (Dollars in thousands) July 29, 2022 2022 (remaining) $ 4,579 2023 17,540 2024 16,164 2025 14,001 2026 8,819 Thereafter 24,086 Total future minimum operating lease payments 85,189 Less: imputed interest 8,593 Present value of operating lease liabilities $ 76,596

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Jul. 29, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Value of Derivatives and Consolidated Balance Sheet Location	The following table presents the fair value and location of the company’s derivative instruments on the Condensed Consolidated Balance Sheets: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Derivative assets: Derivatives designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts $ 17,723 $ 1,235 $ 189 Derivatives not designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts 4,618 309 133 Total derivative assets $ 22,341 $ 1,544 $ 322 Derivative liabilities: Derivatives designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts $ — $ 3,682 $ 1,260 Derivatives not designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts 18 1,554 872 Total derivative liabilities $ 18 $ 5,236 $ 2,132
Schedule of Effects of Master Netting Arrangements on Fair Value of Derivative Contracts Recorded in Consolidated Balance Sheets	The following table presents the effects of the master netting arrangements on the fair value of the company’s derivative instruments that are recorded on the Condensed Consolidated Balance Sheets: (Dollars in thousands) July 29, 2022 July 30, 2021 October 31, 2021 Derivative assets: Forward currency contracts: Gross amount of derivative assets $ 22,424 $ 1,544 $ 423 Derivative liabilities offsetting derivative assets 83 — 101 Net amount of derivative assets $ 22,341 $ 1,544 $ 322 Derivative liabilities: Forward currency contracts: Gross amount of derivative liabilities $ 18 $ 5,849 $ 4,853 Derivative assets offsetting derivative liabilities — 613 2,721 Net amount of derivative liabilities $ 18 $ 5,236 $ 2,132
Schedule of Impact of Derivative Instruments on Consolidated Statements of Earnings for Derivatives Designated as Cash Flow Hedging Instruments	The following table presents the impact and location of the amounts reclassified from AOCL into net earnings on the Condensed Consolidated Statements of Earnings and the impact of derivative instruments on the Condensed Consolidated Statements of Comprehensive Income for the company's derivatives designated as cash flow hedging instruments for the three and nine months ended July 29, 2022 and July 30, 2021: Three Months Ended Gain (Loss) Reclassified from AOCL into Earnings Gain (Loss) Recognized in OCI on Derivatives (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Derivatives designated as cash flow hedging instruments: Forward currency contracts: Net sales $ 1,640 $ (3,113) $ 2,508 $ 7,350 Cost of sales 200 31 (36) 685 Total derivatives designated as cash flow hedging instruments $ 1,840 $ (3,082) $ 2,472 $ 8,035 Nine Months Ended Gain (Loss) Reclassified from AOCL into Earnings Gain Recognized in OCI on Derivatives (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Derivatives designated as cash flow hedging instruments: Forward currency contracts: Net sales $ 1,431 $ (9,325) $ 14,836 $ 620 Cost of sales 164 60 1,207 266 Total derivatives designated as cash flow hedging instruments $ 1,595 $ (9,265) $ 16,043 $ 886 The following tables present the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives designated as cash flow hedging instruments and the related components excluded from effectiveness testing: Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments (Dollars in thousands) July 29, 2022 July 30, 2021 Three Months Ended Net Sales Cost of Sales Net Sales Cost of Sales Condensed Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded $ 1,160,550 $ (760,644) $ 976,836 $ (645,719) Gain (loss) on derivatives designated as cash flow hedging instruments: Forward currency contracts: Amount of gain (loss) reclassified from AOCL into earnings 1,640 200 (3,113) 31 Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 646 $ 627 $ 322 $ 70 Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments (Dollars in thousands) July 29, 2022 July 30, 2021 Nine Months Ended Net Sales Cost of Sales Net Sales Cost of Sales Condensed Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded $ 3,342,678 $ (2,236,927) $ 2,998,929 $ (1,949,823) Gain (loss) on derivatives designated as cash flow hedging instruments: Forward currency contracts: Amount of gain (loss) reclassified from AOCL into earnings 1,431 164 (9,325) 60 Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ (930) $ 1,180 $ 784 $ 366
Schedule of Impact of Derivative Instruments on Consolidated Statements of Earnings for Derivatives Not Designated as Hedging Instruments	The following table presents the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives not designated as cash flow hedging instruments: Three Months Ended Nine Months Ended (Dollars in thousands) July 29, 2022 July 30, 2021 July 29, 2022 July 30, 2021 Gain (loss) on derivatives not designated as cash flow hedging instruments Forward currency contracts: Other income, net $ (344) $ 1,972 $ 3,639 $ (4,511) Total gain (loss) on derivatives not designated as cash flow hedging instruments $ (344) $ 1,972 $ 3,639 $ (4,511)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jul. 29, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present, by level within the fair value hierarchy, the company's financial assets and liabilities that are measured at fair value on a recurring basis as of July 29, 2022, July 30, 2021, and October 31, 2021, according to the valuation technique utilized to determine their fair values (in thousands): Fair Value Measurements Using Inputs Considered as: July 29, 2022 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 22,341 $ — $ 22,341 $ — Total assets $ 22,341 $ — $ 22,341 $ — Liabilities: Forward currency contracts $ 18 $ — $ 18 $ — Total liabilities $ 18 $ — $ 18 $ — Fair Value Measurements Using Inputs Considered as: July 30, 2021 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 1,544 $ — $ 1,544 $ — Total assets $ 1,544 $ — $ 1,544 $ — Liabilities: Forward currency contracts $ 5,236 $ — $ 5,236 $ — Total liabilities $ 5,236 $ — $ 5,236 $ — Fair Value Measurements Using Inputs Considered as: October 31, 2021 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 322 $ — $ 322 $ — Total assets $ 322 $ — $ 322 $ — Liabilities: Forward currency contracts $ 2,132 $ — $ 2,132 $ — Total liabilities $ 2,132 $ — $ 2,132 $ —

Business Combinations and Ass_3

Business Combinations and Asset Acquisitions - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Jan. 13, 2022	Jul. 29, 2022	Jan. 28, 2022	Jul. 29, 2022	Jul. 30, 2021	Oct. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 583,803		$ 583,803	$ 421,958	$ 421,680
Finite-lived intangible asset, useful life			14 years 7 months 6 days	13 years 4 months 24 days	14 years 7 months 6 days
Operating Segments | Professional
Business Acquisition [Line Items]
Goodwill		573,415		$ 573,415		$ 411,079
Trade names
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life			15 years 4 months 24 days	13 years 8 months 12 days	15 years 3 months 18 days
Intimidator
Business Acquisition [Line Items]
Percentage of voting interests acquired	100%
Payments to acquire businesses, gross	$ 398,900
Total purchase price	399,766
Additional cash purchase consideration, maximum	15,000
Goodwill	163,731
Goodwill, purchase accounting adjustments		2,900		$ 8,100
Other intangible assets	$ 184,200
Finite-lived intangible asset, useful life	9 years 6 months
Revenue of acquiree since acquisition date		$ 54,400		$ 114,900
Intimidator | Trade names
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life	9 years 9 months 18 days
Intimidator | Customer-related
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life	9 years 7 months 6 days
Intimidator | Backlog
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life	9 months

Business Combinations and Ass_4

Business Combinations and Asset Acquisitions - Allocation of Preliminary Purchase Price Assigned to the Intimidator Group (Details) - USD ($) $ in Thousands	Jan. 13, 2022	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Business Acquisition [Line Items]
Goodwill		$ 583,803	$ 421,680	$ 421,958
Intimidator
Business Acquisition [Line Items]
Cash and cash equivalents	$ 975
Receivables	6,954
Inventories	34,608
Prepaid expenses and other current assets	513
Property, plant and equipment	27,447
Right-of-use assets	344
Goodwill	163,731
Other intangible assets:
Indefinite-lived trade name	99,100
Accounts payable	(8,535)
Accrued liabilities	(9,152)
Short-term lease liabilities	(100)
Long-term lease liabilities	(244)
Total fair value of net assets acquired	400,741
Less: cash and cash equivalents acquired	(975)
Total purchase price	399,766
Intimidator | Trade names
Other intangible assets:
Finite-lived intangibles	3,260
Intimidator | Customer-related
Other intangible assets:
Finite-lived intangibles	80,500
Intimidator | Backlog
Other intangible assets:
Finite-lived intangibles	$ 1,340

Segment Data - Narrative (Detai

Segment Data - Narrative (Details)	9 Months Ended
	Jul. 29, 2022 segment
Segment Reporting [Abstract]
Operating segments	12
Reportable segments	2

Segment Data - Summarized Finan

Segment Data - Summarized Financial Information of Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021	Oct. 31, 2021
Financial information concerning reportable segments
Net sales	$ 1,160,550	$ 976,836	$ 3,342,678	$ 2,998,929
Earnings (loss) before income taxes	157,091	117,451	409,294	430,520
Total assets	3,439,949	2,968,049	3,439,949	2,968,049	$ 2,936,140
Operating Segments | Professional
Financial information concerning reportable segments
Net sales	886,232	718,477	2,484,927	2,197,058
Earnings (loss) before income taxes	166,191	122,331	424,833	406,279
Total assets	2,625,481	1,949,681	2,625,481	1,949,681
Operating Segments | Residential
Financial information concerning reportable segments
Net sales	269,962	252,117	845,039	784,852
Earnings (loss) before income taxes	26,348	31,548	95,203	109,642
Total assets	407,218	327,064	407,218	327,064
Other Activities
Financial information concerning reportable segments
Net sales	4,356	6,242	12,712	17,019
Earnings (loss) before income taxes	(35,448)	(36,428)	(110,742)	(85,401)
Total assets	407,250	691,304	407,250	691,304
Intersegment gross sales (eliminations)
Financial information concerning reportable segments
Net sales	(10,451)	(8,254)	(23,251)	(24,073)
Intersegment gross sales (eliminations) | Professional
Financial information concerning reportable segments
Net sales	10,436	8,241	23,201	24,034
Intersegment gross sales (eliminations) | Residential
Financial information concerning reportable segments
Net sales	$ 15	$ 13	$ 50	$ 39

Segment Data - Components of Lo

Segment Data - Components of Loss before Income Taxes Included in Other (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Components of the loss before income taxes included in "Other"
Interest expense	$ (9,182)	$ (7,016)	$ (24,219)	$ (21,662)
Earnings from wholly-owned domestic distribution companies and other income, net	3,225	2,528	8,262	8,062
Earnings before income taxes	157,091	117,451	409,294	430,520
Other Activities
Components of the loss before income taxes included in "Other"
Corporate expenses	(30,816)	(33,797)	(94,359)	(78,814)
Interest expense	(9,182)	(7,016)	(24,219)	(21,662)
Earnings from wholly-owned domestic distribution companies and other income, net	4,550	4,385	7,836	15,075
Earnings before income taxes	$ (35,448)	$ (36,428)	$ (110,742)	$ (85,401)

Revenue - Disaggregation by Maj

Revenue - Disaggregation by Major Product Type and Geographic Market (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Disaggregation of Revenue [Line Items]
Revenues	$ 1,160,550	$ 976,836	$ 3,342,678	$ 2,998,929
United States
Disaggregation of Revenue [Line Items]
Revenues	944,408	785,171	2,685,879	2,360,008
International countries
Disaggregation of Revenue [Line Items]
Revenues	216,142	191,665	656,799	638,921
Equipment
Disaggregation of Revenue [Line Items]
Revenues	1,047,309	859,338	2,979,292	2,664,298
Irrigation
Disaggregation of Revenue [Line Items]
Revenues	113,241	117,498	363,386	334,631
Operating Segments | Professional
Disaggregation of Revenue [Line Items]
Revenues	886,232	718,477	2,484,927	2,197,058
Operating Segments | Professional | United States
Disaggregation of Revenue [Line Items]
Revenues	710,386	559,907	1,969,933	1,681,972
Operating Segments | Professional | International countries
Disaggregation of Revenue [Line Items]
Revenues	175,846	158,570	514,994	515,086
Operating Segments | Professional | Equipment
Disaggregation of Revenue [Line Items]
Revenues	780,738	609,022	2,149,549	1,891,138
Operating Segments | Professional | Irrigation
Disaggregation of Revenue [Line Items]
Revenues	105,494	109,455	335,378	305,920
Operating Segments | Residential
Disaggregation of Revenue [Line Items]
Revenues	269,962	252,117	845,039	784,852
Operating Segments | Residential | United States
Disaggregation of Revenue [Line Items]
Revenues	229,666	219,022	703,234	661,017
Operating Segments | Residential | International countries
Disaggregation of Revenue [Line Items]
Revenues	40,296	33,095	141,805	123,835
Operating Segments | Residential | Equipment
Disaggregation of Revenue [Line Items]
Revenues	265,469	247,152	823,536	761,724
Operating Segments | Residential | Irrigation
Disaggregation of Revenue [Line Items]
Revenues	4,493	4,965	21,503	23,128
Other Activities
Disaggregation of Revenue [Line Items]
Revenues	4,356	6,242	12,712	17,019
Other Activities | United States
Disaggregation of Revenue [Line Items]
Revenues	4,356	6,242	12,712	17,019
Other Activities | International countries
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Other Activities | Equipment
Disaggregation of Revenue [Line Items]
Revenues	1,102	3,164	6,207	11,436
Other Activities | Irrigation
Disaggregation of Revenue [Line Items]
Revenues	$ 3,254	$ 3,078	$ 6,505	$ 5,583

Revenue - Contract Liabilities

Revenue - Contract Liabilities (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jul. 29, 2022	Jul. 29, 2022	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract with customer, liability	$ 27.3	$ 27.3	$ 24.1
Contract with customer liability revenue recognized	$ 3.3	$ 8.8

Revenue - Performance Obligatio

Revenue - Performance Obligation (Details) $ in Millions	Jul. 29, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-30
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2.3
Revenue, remaining performance obligation, expected timing of satisfaction, period	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 7.7
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 5.3
Revenue, remaining performance obligation, expected timing of satisfaction, period

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets, Net - Narrative (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Jan. 13, 2022	Oct. 31, 2021	Jul. 30, 2021
Goodwill [Line Items]
Goodwill	$ 583,803		$ 421,680	$ 421,958
Intimidator
Goodwill [Line Items]
Goodwill		$ 163,731
Other intangible assets		$ 184,200

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets, Net - Changes in Net Carrying Amount of Goodwill (Details) $ in Thousands	9 Months Ended
	Jul. 29, 2022 USD ($)
Changes in the net carrying amount of goodwill
Goodwill, balance at beginning of period	$ 421,680
Goodwill acquired	163,731
Translation adjustments	(1,608)
Goodwill, balance at end of period	583,803
Operating Segments | Professional
Changes in the net carrying amount of goodwill
Goodwill, balance at beginning of period	411,079
Goodwill acquired	163,731
Translation adjustments	(1,395)
Goodwill, balance at end of period	573,415
Operating Segments | Residential
Changes in the net carrying amount of goodwill
Goodwill, balance at beginning of period	10,601
Goodwill acquired	0
Translation adjustments	(213)
Goodwill, balance at end of period	10,388
Other Activities
Changes in the net carrying amount of goodwill
Goodwill, balance at beginning of period	0
Goodwill acquired	0
Translation adjustments	0
Goodwill, balance at end of period	$ 0

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Jul. 29, 2022	Jan. 28, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021	Oct. 31, 2021
Other Intangible Assets
Weighted-Average Useful Life in Years		14 years 7 months 6 days		13 years 4 months 24 days	14 years 7 months 6 days
Gross Carrying Amount	$ 464,684		$ 364,391	$ 464,684	$ 364,391	$ 364,263
Accumulated Amortization	(159,015)		(128,575)	(159,015)	(128,575)	(134,866)
Net	305,669		235,816	305,669	235,816	229,397
Indefinite-lived - trade names	289,472		190,681	289,472	190,681	190,644
Total other intangible assets, gross	754,156		555,072	754,156	555,072	554,907
Total other intangible assets, net	595,141		426,497	595,141	426,497	420,041
Estimated amortization expense
Amortization of other intangible assets	9,100		6,400	24,800	$ 17,500
Fiscal 2022 (remainder)	9,100			9,100
Fiscal 2023	34,900			34,900
Fiscal 2024	33,000			33,000
Fiscal 2025	30,100			30,100
Fiscal 2026	29,000			29,000
Fiscal 2027	24,000			24,000
After fiscal 2027	145,600			$ 145,600
Patents
Other Intangible Assets
Weighted-Average Useful Life in Years		9 years 10 months 24 days		9 years 10 months 24 days	9 years 10 months 24 days
Gross Carrying Amount	18,252		18,275	$ 18,252	$ 18,275	18,283
Accumulated Amortization	(15,178)		(14,482)	(15,178)	(14,482)	(14,670)
Net	3,074		3,793	$ 3,074	$ 3,793	3,613
Non-compete agreements
Other Intangible Assets
Weighted-Average Useful Life in Years		5 years 6 months		5 years 6 months	5 years 6 months
Gross Carrying Amount	6,887		6,908	$ 6,887	$ 6,908	6,914
Accumulated Amortization	(6,861)		(6,861)	(6,861)	(6,861)	(6,872)
Net	26		47	$ 26	$ 47	42
Customer-related
Other Intangible Assets
Weighted-Average Useful Life in Years		18 years 2 months 12 days		16 years	18 years 2 months 12 days
Gross Carrying Amount	321,113		239,762	$ 321,113	$ 239,762	239,679
Accumulated Amortization	(78,017)		(59,017)	(78,017)	(59,017)	(62,617)
Net	243,096		180,745	$ 243,096	$ 180,745	177,062
Developed technology
Other Intangible Assets
Weighted-Average Useful Life in Years		7 years		7 years 1 month 6 days	7 years
Gross Carrying Amount	102,013		87,512	$ 102,013	$ 87,512	87,473
Accumulated Amortization	(50,412)		(40,943)	(50,412)	(40,943)	(43,348)
Net	51,601		46,569	$ 51,601	$ 46,569	44,125
Trade names
Other Intangible Assets
Weighted-Average Useful Life in Years		15 years 4 months 24 days		13 years 8 months 12 days	15 years 3 months 18 days
Gross Carrying Amount	10,689		7,544	$ 10,689	$ 7,544	7,524
Accumulated Amortization	(3,267)		(2,882)	(3,267)	(2,882)	(2,969)
Net	7,422		4,662	$ 7,422	$ 4,662	4,555
Backlog and other
Other Intangible Assets
Weighted-Average Useful Life in Years		7 months 6 days		7 months 6 days	7 months 6 days
Gross Carrying Amount	5,730		4,390	$ 5,730	$ 4,390	4,390
Accumulated Amortization	(5,280)		(4,390)	(5,280)	(4,390)	(4,390)
Net	$ 450		$ 0	$ 450	$ 0	$ 0

Indebtedness - Summary of Debt

Indebtedness - Summary of Debt (Details) - USD ($)	Jul. 29, 2022	Jun. 30, 2022	Apr. 27, 2022	Oct. 31, 2021	Jul. 30, 2021
Debt Instrument [Line Items]
Less: unamortized discounts, debt issuance costs, and deferred charges	$ 3,470,000			$ 2,798,000	$ 2,462,000
Total long-term debt	1,055,616,000			691,242,000	691,562,000
Less: current portion of long-term debt	65,000,000			0	104,217,000
Long-term debt, less current portion	990,616,000			691,242,000	587,345,000
Line of Credit | $600 million revolving credit facility, due October 2026
Debt Instrument [Line Items]
Long-term debt, gross	65,000,000			0	0
Debt instrument, face amount	600,000,000
Senior Notes | $200 million term loan, due April 2022
Debt Instrument [Line Items]
Long-term debt, gross	0			0	100,000,000
Debt instrument, face amount	200,000,000
Senior Notes | $300 million term loan, due April 2024
Debt Instrument [Line Items]
Long-term debt, gross	0			0	170,000,000
Debt instrument, face amount	300,000,000
Senior Notes | $270 million term loan, due October 2026
Debt Instrument [Line Items]
Long-term debt, gross	270,000,000			270,000,000	0
Debt instrument, face amount	270,000,000
Senior Notes | $200 million term loan, due April 2027
Debt Instrument [Line Items]
Long-term debt, gross	200,000,000			0	0
Debt instrument, face amount	200,000,000		$ 200,000,000
Debt instrument, interest rate, stated percentage			2.50%
Senior Notes | 3.81% series A senior notes, due June 2029
Debt Instrument [Line Items]
Long-term debt, gross	$ 100,000,000			100,000,000	100,000,000
Debt instrument, interest rate, stated percentage	3.81%
Senior Notes | 3.91% series B senior notes, due June 2031
Debt Instrument [Line Items]
Long-term debt, gross	$ 100,000,000			100,000,000	100,000,000
Debt instrument, interest rate, stated percentage	3.91%
Senior Notes | 3.97% senior notes, due June 2032
Debt Instrument [Line Items]
Long-term debt, gross	$ 100,000,000			0	0
Debt instrument, face amount		$ 100,000,000
Debt instrument, interest rate, stated percentage	3.97%	3.97%
Senior Notes | 6.625% senior notes, due May 2037
Debt Instrument [Line Items]
Long-term debt, gross	$ 124,086,000			124,040,000	124,024,000
Debt instrument, interest rate, stated percentage	6.625%
Corporate Debt Securities | 7.8% debentures, due June 2027
Debt Instrument [Line Items]
Long-term debt, gross	$ 100,000,000			$ 100,000,000	$ 100,000,000
Debt instrument, interest rate, stated percentage	7.80%

Indebtedness - Narrative (Detai

Indebtedness - Narrative (Details)	Jul. 29, 2022 USD ($)	Jun. 30, 2022 USD ($) d	Apr. 27, 2022 USD ($)	Oct. 31, 2021 USD ($)	Jul. 30, 2021 USD ($)
Debt Instrument [Line Items]
Fiscal 2022 (remainder)	$ 0
Fiscal 2023	0
Fiscal 2024	0
Fiscal 2025	37,000,000
Fiscal 2026	328,000,000
Fiscal 2027	270,000,000
After fiscal 2027	425,000,000
Current portion of long-term debt	$ 65,000,000			$ 0	$ 104,217,000
3.97% senior notes, due June 2032 | Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount		$ 100,000,000
Debt instrument, interest rate, stated percentage	3.97%	3.97%
Face amount to be paid, percentage		100%
Repayment period | d		90
$200 million term loan, due April 2027 | Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount	$ 200,000,000		$ 200,000,000
Debt instrument, interest rate, stated percentage			2.50%

Inventories, Net - Narrative (D

Inventories, Net - Narrative (Details) $ in Thousands	Jan. 13, 2022 USD ($)
Intimidator
Business Acquisition [Line Items]
Inventory acquired	$ 34,608

Inventories, Net (Details)

Inventories, Net (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 402,719	$ 335,325	$ 280,774
Finished goods and service parts	672,042	538,332	466,961
Total FIFO and average cost value	1,074,761	873,657	747,735
Less: adjustment to LIFO value	135,487	135,487	82,087
Total inventories, net	$ 939,274	$ 738,170	$ 665,648

Property, Plant and Equipment_3

Property, Plant and Equipment, Net - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 29, 2022	Jan. 13, 2022
Intimidator
Property, Plant and Equipment [Line Items]
Property, plant and equipment		$ 27,447
Buildings and leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	10 years
Buildings and leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	40 years
Equipment | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Equipment | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	15 years
Tooling | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Tooling | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Software and Software Development Costs | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	2 years
Software and Software Development Costs | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years

Property, Plant and Equipment_4

Property, Plant and Equipment, Net - Summary of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 1,378,210	$ 1,292,092	$ 1,281,546
Less: accumulated depreciation	846,394	804,361	824,554
Property, plant, and equipment, net	531,816	487,731	456,992
Land and land improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	57,169	57,690	56,004
Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	326,111	308,217	299,484
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	535,303	522,012	508,383
Tooling
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	221,290	220,966	233,171
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	96,834	97,485	102,293
Construction in process
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 141,503	$ 85,722	$ 82,211

Product Warranty Guarantees (De

Product Warranty Guarantees (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Warranty provisions, claims, and changes in estimates
Balance at beginning of period	$ 126,830	$ 119,389	$ 116,783	$ 107,121
Provisions	21,824	17,686	62,917	56,204
Acquisitions	2,466	0	5,663	0
Claims	(20,829)	(20,300)	(54,601)	(51,104)
Changes in estimates	727	377	256	4,931
Balance at end of period	$ 131,018	$ 117,152	$ 131,018	$ 117,152

Investment in Finance Affilia_2

Investment in Finance Affiliate (Details) - USD ($)	9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Oct. 31, 2021
Schedule of Equity Method Investments
Total assets	$ 3,439,949,000	$ 2,968,049,000	$ 2,936,140,000
Red Iron Acceptance, LLC
Schedule of Equity Method Investments
Maximum aggregate amount of products repossessed by Red Iron and the TCFIF Canadian affiliate, entity has agreed to repurchase in a calendar year (up to)	7,500,000
Net amount of new receivables financed for dealers and distributors	1,886,100,000	1,733,000,000
Related party transaction, due from (to) related party, current	$ 14,400,000	13,800,000	31,000,000
Portion owned by Toro	45%
Portion owned by TCFIF	55%
Investment in joint venture	$ 31,400,000	$ 19,300,000	$ 20,700,000
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Schedule of Equity Method Investments
Total assets	641,600,000
Total liabilities	571,900,000
Maximum borrowing capacity under credit facility	$ 625,000,000

Stock-Based Compensation - Comp

Stock-Based Compensation - Compensation Costs Related to Stock-Based Awards Granted (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	$ 5,972	$ 5,831	$ 17,105	$ 16,176
Stock option awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	2,664	2,614	7,207	7,271
Performance share awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	1,697	2,184	5,235	5,205
Restricted stock unit awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	1,611	1,033	4,034	3,029
Unrestricted common stock awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	$ 0	$ 0	$ 629	$ 671

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Option Awards, Performance Share Awards, Restricted Stock Unit Awards and Unrestricted Common Stock Awards (Details) - $ / shares	3 Months Ended				9 Months Ended
	Jul. 29, 2022	Apr. 29, 2022	Jul. 30, 2021	Apr. 30, 2021	Jul. 29, 2022	Jul. 30, 2021	Mar. 15, 2022	Oct. 31, 2021
Stock-Based Compensation
Common stock, authorized (in shares)	175,000,000		175,000,000		175,000,000	175,000,000		175,000,000
2022 Plan
Stock-Based Compensation
Common stock, authorized (in shares)							1,250,000
Stock option awards
Stock-Based Compensation
Vesting period					3 years
Term of options					10 years
Performance share awards
Stock-Based Compensation
Performance goal period					3 years
Weighted-average fair value of awards granted (in dollars per share)	$ 98.41		$ 90.59
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period (in shares)	0	0	0	0
Performance share awards | Maximum
Stock-Based Compensation
Vesting percentage					200%
Performance share awards | Minimum
Stock-Based Compensation
Vesting percentage					0%
Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting period					3 years
Weighted-average fair value of awards granted (in dollars per share)					$ 89.19	$ 97.84
Unrestricted common stock awards
Stock-Based Compensation
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period (in shares)	0	0	0	0
Unrestricted common stock awards | Board of Directors
Stock-Based Compensation
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period (in shares)					6,453,000	8,070,000
Tranche One | Stock option awards | Board of Directors
Stock-Based Compensation
Vesting percentage					33.33%
Tranche One | Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting percentage					33.33%
Tranche Two | Stock option awards | Board of Directors
Stock-Based Compensation
Vesting percentage					33.33%
Tranche Two | Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting percentage					33.33%
Tranche Three | Stock option awards | Board of Directors
Stock-Based Compensation
Vesting percentage					33.33%
Tranche Three | Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting percentage					33.33%

Stock-Based Compensation - Assu

Stock-Based Compensation - Assumptions for Options Granted (Details) - $ / shares	9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021
Stock-Based Compensation
Per share weighted-average fair value at date of grant (in dollars per share)	$ 22.55	$ 19.39
Stock option awards
Stock-Based Compensation
Expected life of option in years	6 years 2 months 8 days	6 years 2 months 15 days
Expected stock price volatility	23.74%	23.26%
Risk-free interest rate	1.31%	0.55%
Expected dividend yield	0.94%	0.86%

Stockholders' Equity - Componen

Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Accumulated other comprehensive loss (AOCL)
Foreign currency translation adjustments	$ 40,725	$ 19,535	$ 17,823
Pension benefits	3,899	3,899	5,106
Cash flow derivative instruments	(13,481)	2,562	3,762
Total accumulated other comprehensive loss	$ 31,143	$ 25,996	$ 26,691

Stockholders' Equity - Compon_2

Stockholders' Equity - Components and Activity of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Components and activity of accumulated other comprehensive loss
Balance at beginning of period	$ (1,223,516)	$ (1,229,417)	$ (1,151,132)	$ (1,114,828)
Other comprehensive income before reclassifications	5,160	(5,803)	6,742	(16,836)
Amounts reclassified from AOCL	(1,840)	3,082	(1,595)	9,265
Net current period other comprehensive income	3,320	(2,721)	5,147	(7,571)
Balance at end of period	(1,286,602)	(1,237,178)	(1,286,602)	(1,237,178)
Accumulated Other Comprehensive Loss
Components and activity of accumulated other comprehensive loss
Balance at beginning of period	27,823	29,412	25,996	34,262
Net current period other comprehensive income	3,320	(2,721)	5,147	(7,571)
Balance at end of period	31,143	26,691	31,143	26,691
Foreign  Currency Translation Adjustments
Components and activity of accumulated other comprehensive loss
Balance at beginning of period	34,933	12,509	19,535	24,508
Other comprehensive income before reclassifications	5,792	5,314	21,190	(6,685)
Amounts reclassified from AOCL	0	0	0	0
Net current period other comprehensive income	5,792	5,314	21,190	(6,685)
Balance at end of period	40,725	17,823	40,725	17,823
Pension Benefits
Components and activity of accumulated other comprehensive loss
Balance at beginning of period	3,899	5,106	3,899	5,106
Other comprehensive income before reclassifications	0	0	0	0
Amounts reclassified from AOCL	0	0	0	0
Net current period other comprehensive income	0	0	0	0
Balance at end of period	3,899	5,106	3,899	5,106
Cash Flow Derivative Instruments
Components and activity of accumulated other comprehensive loss
Balance at beginning of period	(11,009)	11,797	2,562	4,648
Other comprehensive income before reclassifications	(632)	(11,117)	(14,448)	(10,151)
Amounts reclassified from AOCL	(1,840)	3,082	(1,595)	9,265
Net current period other comprehensive income	(2,472)	(8,035)	(16,043)	(886)
Balance at end of period	$ (13,481)	$ 3,762	$ (13,481)	$ 3,762

Per Share Data (Details)

Per Share Data (Details) - shares	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Basic
Weighted-average number of shares of common stock (in shares)	104,827,000	107,130,000	104,924,000	107,661,000
Assumed issuance of contingent shares (in shares)	0	0	7,000	6,000
Weighted-average number of shares of common stock outstanding — Basic (in shares)	104,827,000	107,130,000	104,931,000	107,667,000
Diluted
Weighted-average number of shares of common stock outstanding — Basic (in shares)	104,827,000	107,130,000	104,931,000	107,667,000
Effect of dilutive shares (in shares)	621,000	1,233,000	823,000	1,151,000
Weighted-average number of shares of common stock outstanding — Diluted (in shares)	105,448,000	108,363,000	105,754,000	108,818,000
Options, restricted stock, and restricted stock units, excluded from the diluted earnings per share (in shares)	1,066,621,000	2,109	896,184,000	425,748

Contingencies (Details)

Contingencies (Details) - Exmark Manufacturing Company Incorporated v. Briggs & Stratton Corporation $ in Thousands	Nov. 19, 2020 USD ($)
Loss Contingencies [Line Items]
Litigation settlement, amount awarded to other party	$ 33,650
Litigation settlement, percentage of the settlement amount	50%

Leases - Lease Expense Incurred

Leases - Lease Expense Incurred (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Leases [Abstract]
Operating lease expense	$ 3,833	$ 4,397	$ 16,304	$ 14,488
Short-term lease expense	303	256	3,445	1,693
Variable lease expense	12	22	12	72
Total lease expense	$ 4,148	$ 4,675	$ 19,761	$ 16,253

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow and Other Lease Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021
Leases [Abstract]
Operating cash flows for amounts included in the measurement of lease liabilities	$ 14,129	$ 14,288
Right-of-use assets obtained in exchange for lease obligations	$ 18,236	$ 4,739

Leases - Summary of Other Lease

Leases - Summary of Other Lease Information (Details)	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Leases [Abstract]
Weighted-average remaining lease term of operating leases in years	6 years 2 months 12 days	6 years 7 months 6 days	6 years 7 months 6 days
Weighted-average discount rate of operating leases	2.99%	2.71%	2.70%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Operating Lease Payments (Details) $ in Thousands	Jul. 29, 2022 USD ($)
ASC Topic 842 Leases
2022 (remaining)	$ 4,579
2023	17,540
2024	16,164
2025	14,001
2026	8,819
Thereafter	24,086
Total future minimum operating lease payments	85,189
Less: imputed interest	8,593
Present value of operating lease liabilities	$ 76,596

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities - Narrative (Details) $ in Millions	9 Months Ended
	Jul. 29, 2022 USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Maximum length of time hedged in cash flow hedge	2 years
Cash flow hedge effectiveness measurement period	2 months
Gains to be reclassified from AOCL to earnings	$ 12.4
Forward currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, notional amount	$ 293

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities - Fair Value and Location of Derivative Instruments (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Fair value of derivatives
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Prepaid expenses and other current assets	Prepaid expenses and other current assets	Prepaid expenses and other current assets
Derivative assets	$ 22,341	$ 322	$ 1,544
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities	Accrued liabilities
Derivative liabilities	$ 18	$ 2,132	$ 5,236
Forward currency contracts
Fair value of derivatives
Derivative assets	22,341	322	1,544
Derivative liabilities	18	2,132	5,236
Forward currency contracts | Derivatives designated as cash flow hedging instruments:
Fair value of derivatives
Derivative assets	17,723	189	1,235
Derivative liabilities	0	1,260	3,682
Forward currency contracts | Derivatives not designated as cash flow hedging instruments:
Fair value of derivatives
Derivative assets	4,618	133	309
Derivative liabilities	$ 18	$ 872	$ 1,554

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities - Effects of Master Netting Arrangements (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Derivative assets:
Net amount of derivative assets	$ 22,341	$ 322	$ 1,544
Derivative liabilities:
Net amount of derivative liabilities	18	2,132	5,236
Forward currency contracts
Derivative assets:
Gross amount of derivative assets	22,424	423	1,544
Derivative liabilities offsetting derivative assets	83	101	0
Net amount of derivative assets	22,341	322	1,544
Derivative liabilities:
Gross amount of derivative liabilities	18	4,853	5,849
Derivative assets offsetting derivative liabilities	0	2,721	613
Net amount of derivative liabilities	$ 18	$ 2,132	$ 5,236

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities - Impact and Location of Amounts Reclassified from AOCL and Impacts and Location on OCI (Details) - Cash flow hedging - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	$ 1,840	$ (3,082)	$ 1,595	$ (9,265)
Gain (Loss) Recognized in OCI on Derivatives	2,472	8,035	16,043	886
Forward currency contracts | Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	1,640	(3,113)	1,431	(9,325)
Gain (Loss) Recognized in OCI on Derivatives	2,508	7,350	14,836	620
Forward currency contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	200	31	164	60
Gain (Loss) Recognized in OCI on Derivatives	$ (36)	$ 685	$ 1,207	$ 266

Derivative Instruments and He_7

Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Net sales	$ 1,160,550	$ 976,836	$ 3,342,678	$ 2,998,929
Cost of Sales	(760,644)	(645,719)	(2,236,927)	(1,949,823)
Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) reclassified from AOCL into earnings	1,840	(3,082)	1,595	(9,265)
Net Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Net sales	1,160,550	976,836	3,342,678	2,998,929
Cost of Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Cost of Sales	(760,644)	(645,719)	(2,236,927)	(1,949,823)
Forward currency contracts | Net Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) reclassified from AOCL into earnings	1,640	(3,113)	1,431	(9,325)
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value	646	322	(930)	784
Forward currency contracts | Cost of Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) reclassified from AOCL into earnings	200	31	164	60
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value	$ 627	$ 70	$ 1,180	$ 366

Derivative Instruments and He_8

Derivative Instruments and Hedging Activities - Impact and Location of Derivatives Not Designated As Cash Flow Hedging Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2022	Jul. 30, 2021	Jul. 29, 2022	Jul. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Earnings from wholly-owned domestic distribution companies and other income, net	Earnings from wholly-owned domestic distribution companies and other income, net	Earnings from wholly-owned domestic distribution companies and other income, net	Earnings from wholly-owned domestic distribution companies and other income, net
Derivatives not designated as cash flow hedging instruments:
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$ (344)	$ 1,972	$ 3,639	$ (4,511)
Forward currency contracts | Derivatives not designated as cash flow hedging instruments:
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$ (344)	$ 1,972	$ 3,639	$ (4,511)

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Assets:
Forward currency contracts	$ 22,341	$ 322	$ 1,544
Liabilities:
Forward currency contracts	18	2,132	5,236
Forward currency contracts
Assets:
Forward currency contracts	22,341	322	1,544
Liabilities:
Forward currency contracts	18	2,132	5,236
Measured on a recurring basis
Assets:
Total assets	22,341	322	1,544
Liabilities:
Total liabilities	18	2,132	5,236
Measured on a recurring basis | Forward currency contracts
Assets:
Forward currency contracts	22,341	322	1,544
Liabilities:
Forward currency contracts	18	2,132	5,236
Measured on a recurring basis | Level 1
Assets:
Total assets	0	0	0
Liabilities:
Total liabilities	0	0	0
Measured on a recurring basis | Level 1 | Forward currency contracts
Assets:
Forward currency contracts	0	0	0
Liabilities:
Forward currency contracts	0	0	0
Measured on a recurring basis | Level 2
Assets:
Total assets	22,341	322	1,544
Liabilities:
Total liabilities	18	2,132	5,236
Measured on a recurring basis | Level 2 | Forward currency contracts
Assets:
Forward currency contracts	22,341	322	1,544
Liabilities:
Forward currency contracts	18	2,132	5,236
Measured on a recurring basis | Level 3
Assets:
Total assets	0	0	0
Liabilities:
Total liabilities	0	0	0
Measured on a recurring basis | Level 3 | Forward currency contracts
Assets:
Forward currency contracts	0	0	0
Liabilities:
Forward currency contracts	$ 0	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	Jul. 29, 2022	Oct. 31, 2021	Jul. 30, 2021
Assets and liabilities measured at fair value disclosures
Long-term debt, percentage bearing fixed interest, amount	$ 524.1	$ 424	$ 424
Level 2
Assets and liabilities measured at fair value disclosures
Long-term debt, fair value	$ 541	$ 517.9	$ 525.9